2022
| Publication Reference |
| Frydman JL, Berkalieva A, Liu B, Scarborough BM, Mazumdar M, Smith CB. Telemedicine Utilization in the Ambulatory Palliative Care Setting: Are There Disparities? J Pain Symptom Manage. 2022 Mar;63(3):423-429. doi: 10.1016/j.jpainsymman.2021.09.019. Epub 2021 Oct 10. PMID: 34644615; PMCID: PMC8854351. |
| Asfaw ZK, Soto E, Yaeger K, Feng R, Carrasquilla A, Barthélemy EJ, Tabani H, Berkalieva A, Mazumdar M, McNeill IT, Germano IM. Racial and Ethnical Diversity Within the Neurosurgery Resident and Faculty Workforce in the United States. Neurosurgery. 2022 Jul 1;91(1):72-79. doi: 10.1227/neu.0000000000001920. Epub 2022 Apr 8. PMID: 35384926. |
| Phillips KA, Trosman JR, Douglas MP, Gelb BD, Ferket BS, Hindorff LA, Slavotinek AM, Berg JS, Russell HV, Devine B, Greve V, Smith HS. US private payers’ perspectives on insurance coverage for genome sequencing versus exome sequencing: A study by the Clinical Sequencing Evidence-Generating Research Consortium (CSER). Genet Med. 2022 Jan;24(1):238-244. doi: 10.1016/j.gim.2021.08.009. Epub 2021 Nov 30. PMID: 34906461; PMCID: PMC8962136. |
| Ferket BS, Baldwin Z, Murali P, Pai A, Mittendorf KF, Russell HV, Chen F, Lynch FL, Lich KH, Hindorff LA, Savich R, Slavotinek A, Smith HS, Gelb BD, Veenstra DL. Cost-effectiveness frameworks for comparing genome and exome sequencing versus conventional diagnostic pathways: A scoping review and recommended methods. Genet Med. 2022 Oct;24(10):2014-2027. doi: 10.1016/j.gim.2022.06.004. Epub 2022 Jul 14. PMID: 35833928. |
| Borowsky PA, Choi S, Moore JF, White A, Morin C, Net J, Kesmodel SB, Goel N, Kwon D, Griffiths A, Feinberg JA, Zelenko N, Manasseh M, Borgen P, Rojas KE. The Association of Preoperative Magnetic Resonance Imaging (MRI) With Surgical Management in Patients With Early-Stage Breast Cancer. J Surg Res. 2022 Dec;280:114-122. doi: 10.1016/j.jss.2022.06.066. Epub 2022 Aug 11. PMID: 35964483. |
| Zaveri S, Nevid D, Ru M, Moshier E, Pisapati K, Reyes SA, Port E, Romanoff A. Racial Disparities in Time to Treatment Persist in the Setting of a Comprehensive Breast Center. Ann Surg Oncol. 2022 Oct;29(11):6692-6703. doi: 10.1245/s10434-022-11971-w. Epub 2022 Jun 13. PMID: 35697955. |
| Tremblay D, Srisuwananukorn A, Ronner L, Podoltsev N, Gotlib J, Heaney ML, Kuykendall A, O’Connell CL, Shammo JM, Fleischman A, Mesa R, Yacoub A, Hoffman R, Moshier E, Zubizarreta N, Mascarenhas J. European LeukemiaNet Response Predicts Disease Progression but Not Thrombosis in Polycythemia Vera. Hemasphere. 2022 May 11;6(6):e721. doi: 10.1097/HS9.0000000000000721. PMID: 35747843; PMCID: PMC9208865. |
| Rosen DC, Winoker JS, Mullen G, Moshier E, Sim A, Pathak P, Wagaskar V, Sfakianos JP, Reddy A, Palese M, Badani KK, Wiklund P, Tewari A, Mehrazin R. Robot-assisted vs ultrasonography-guided transversus abdominis plane (TAP) block vs local anaesthesia in urology: results of the UROTAP randomized trial. BJU Int. 2022 Dec;130(6):815-822. doi: 10.1111/bju.15833. Epub 2022 Jul 12. PMID: 35727844. |
| Patel R, Hovstadius M, Kier MW, Moshier EL, Zimmerman BS, Cascetta K, Jaffer S, Sparano JA, Tiersten A. Correlation of the Ki67 Working Group prognostic risk categories with the Oncotype DX Recurrence Score in early breast cancer. Cancer. 2022 Oct;128(20):3602-3609. doi: 10.1002/cncr.34426. Epub 2022 Aug 10. PMID: 35947048; PMCID: PMC9529824. |
| Pan D, Kaufman JL, Htut M, Agrawal M, Mazumder A, Cornell RF, Zonder JA, Fay JW, Modiano MR, Moshier EL, Rush SA, Tunquist BJ, Chari A. Filanesib plus bortezomib and dexamethasone in relapsed/refractory t(11;14) and 1q21 gain multiple myeloma. Cancer Med. 2022 Jan;11(2):358-370. doi: 10.1002/cam4.4451. Epub 2021 Dec 17. PMID: 34921527; PMCID: PMC8729045. |
| Nehlsen AD, Sindhu KK, Wolken T, Khan F, Kyriakakos CK, Ward SC, Moshier E, Taouli B, Buckstein M. Characterization and Prediction of Signal Intensity Changes in Normal Liver Parenchyma on Gadoxetic Acid-enhanced MRI Scans after Liver-directed Radiation Therapy. Radiol Imaging Cancer. 2022 Jul;4(4):e210100. doi: 10.1148/rycan.210100. PMID: 35904411; PMCID: PMC9358658. |
| Nehlsen AD, Sindhu KK, Moshier E, Richter J, Richard S, Chari A, Sanchez L, Parekh S, Cho HJ, Jagannath S, Dharmarajan K. The Safety and Efficacy of Radiation Therapy with Concurrent Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin-Based Systemic Therapy for Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2022 Mar;22(3):192-197. doi: 10.1016/j.clml.2021.09.015. Epub 2021 Sep 24. PMID: 34736880; PMCID: PMC9040190. |
| Mouhieddine TH, Hieulle J, Moshier E, Richard S, Richter J, Cho HJ, Parekh S, Barlogie B, Chari A, Jagannath S, Madduri D. Treatment Bridging With a 28-Day Metronomic Therapy (Metro-28) for Relapsed Refractory Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2022 Feb;22(2):129-132. doi: 10.1016/j.clml.2021.09.004. Epub 2021 Sep 11. PMID: 34670732. |
| Mouhieddine TH, Van Oekelen O, Melnekoff DT, Li J, Ghodke-Puranik Y, Lancman G, Thibaud S, Pan D, Rajeeve S, Agte S, Aleman A, Sanchez L, Richard S, Rossi A, Richter J, Cho HJ, Rodriguez C, Lagana A, Moshier EL, Chari A, Jagannath S, Parekh S. Sequencing T-cell redirection therapies leads to deep and durable responses in relapsed/refractory myeloma patients. Blood Adv. 2022 Aug 26:bloodadvances.2022007923. doi: 10.1182/bloodadvances.2022007923. Epub ahead of print. PMID: 36018226. |
| Martins Maia C, Siderides C, Jaffer S, Weltz C, Cate S, Ahn S, Boolbol S, Ru M, Moshier E, Port E, Schmidt H. Mastectomy or Margin Re-excision? A Nomogram for Close/Positive Margins After Lumpectomy for DCIS. Ann Surg Oncol. 2022 Jun;29(6):3740-3748. doi: 10.1245/s10434-021-11293-3. Epub 2022 Jan 22. PMID: 35066720. |
| Karzai S, Port E, Siderides C, Valente C, Ahn S, Moshier E, Ru M, Pisapati K, Couri R, Margolies L, Schmidt H, Cate S. Impact of Screening Mammography on Treatment in Young Women Diagnosed with Breast Cancer. Ann Surg Oncol. 2022 Apr 1. doi: 10.1245/s10434-022-11581-6. Epub ahead of print. PMID: 35364765. |
| Berger NF, Zimmerman BS, Seidman D, Cascetta KP, Moshier E, Nezolosky M, Trlica K, Ryncarz A, Keeton C, Tiersten A. Impact of the COVID-19 Pandemic on Cancer Care and Quality of Life for Patients With Breast and Gynecologic Malignancies: A Single-Center Survey- based Study. J Patient Exp. 2022 Feb 14;9:23743735221077543. doi: 10.1177/23743735221077543. PMID: 35187223; PMCID: PMC8850998. |
| Caro J, Madero-Marroquin R, Zubizarreta N, Moshier E, Tremblay D, Coltoff A, Lancman G, Fuller R, Rana M, Mascarenhas J, Jacobs SE. Impact of Fluoroquinolone Prophylaxis on Neutropenic Fever, Infections, and Antimicrobial Resistance in Newly Diagnosed AML Patients. Clin Lymphoma Myeloma Leuk. 2022 Dec;22(12):903-911. doi: 10.1016/j.clml.2022.08.001. Epub 2022 Aug 7. PMID: 36109322. |
| Takahashi M, Hwang M, Misiukiewicz K, Gupta V, Miles BA, Bakst R, Genden E, Selkridge I, Botzler J, Virani V, Moshier E, Bonomi MR, Posner MR. Quality of Life Analysis of HPV-Positive Oropharyngeal Cancer Patients in a Randomized Trial of Reduced-Dose Versus standard Chemoradiotherapy: 5-Year Follow-Up. Front Oncol. 2022 Apr 8;12:859992. doi: 10.3389/fonc.2022.859992. PMID: 35463348; PMCID: PMC9024140. |
| Goldstone SE, Terlizzi J, Levine R, Moshier E, Pereira Vera B. A Prospective, Dual-Center Trial Of Circumferential Radiofrequency Ablation of Anal High-Grade Squamous Intraepithelial Lesions Demonstrate Improved Long-term Efficacy Over Historical Controls of Targeted Ablation. Dis Colon Rectum. 2022 May 4. doi: 10.1097/DCR.0000000000002365. Epub ahead of print. PMID: 35522783. |
| Alberty-Oller JJ, Reyes S, Moshier E, Ru M, Weltz S, Santos A, Pisapati K, Port E, Jaffer S. Does previous history of cancer or atypia predict histologic upgrade for pure intraductal papillomas diagnosed via core biopsy? A study of 490 cases at a single institution. Cancer Rep (Hoboken). 2022 Mar;5(3):e1481. doi: 10.1002/cnr2.1481. Epub 2021 Nov 2. PMID: 34729946; PMCID: PMC8955065. |
| Wu LM, Valdimarsdottir HB, Amidi A, Reid KJ, Ancoli-Israel S, Bovbjerg K, Fox RS, Walker L, Matharu A, Kaseda ET, Galvin JP, Adekola K, Winkel G, Penedo F, Redd WH. Examining the Efficacy of Bright Light Therapy on Cognitive Function in Hematopoietic Stem Cell Transplant Survivors. J Biol Rhythms. 2022 Oct;37(5):471-483. doi: 10.1177/07487304221107833. Epub 2022 Jul 29. Erratum in: J Biol Rhythms. 2022 Sep 1;:7487304221120697. PMID: 35904252; PMCID: PMC9645769. |
| Shah NJ, Patel VG, Zhong X, Pina L, Hawley JE, Lin E, Gartrell BA, Febles VA, Wise DR, Qin Q, Mellgard G, Joshi H, Nauseef JT, Green DA, Vlachostergios PJ, Kwon DH, Huang F, Liaw B, Tagawa S, Kantoff P, Morris MJ, Oh WK. The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer. JNCI Cancer Spectr. 2022 May 2;6(3):pkac035. doi: 10.1093/jncics/pkac035. PMID: 35657341; PMCID: PMC9165550. |
| Qin Q, Jun T, Wang B, Patel VG, Mellgard G, Zhong X, Gogerly-Moragoda M, Parikh AB, Leiter A, Gallagher EJ, Alerasool P, Garcia P, Joshi H, Mbbs, Galsky M, Oh WK, Tsao CK. Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysis. Discov Oncol. 2022 Aug 12;13(1):73. doi: 10.1007/s12672-022-00538-6. PMID: 35960456; PMCID: PMC9374856. |
| Pedraza AM, Parekh S, Joshi H, Grauer R, Wagaskar V, Zuluaga L, Gupta R, Barthe F, Nasri J, Pandav K, Patel D, Gorin MA, Menon M, Tewari AK. Side- specific, Microultrasound-based Nomogram for the Prediction of Extracapsular Extension in Prostate Cancer. Eur Urol Open Sci. 2022 Dec 28;48:72-81. doi: 10.1016/j.euros.2022.12.005. PMID: 36743400; PMCID: PMC9895764. |
| Mellgard G, Patel VG, Zhong X, Joshi H, Qin Q, Wang B, Parikh A, Jun T, Alerasool P, Garcia P, Gogerly-Moragoda M, Leiter A, Gallagher EJ, Oh WK, Galsky MD, Tsao CK. Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumors. J Cancer Res Clin Oncol. 2022 Jul 5. doi: 10.1007/s00432-022-04159-y. Epub ahead of print. PMID: 35788726. |
| Martini A, Yu M, Raggi D, Joshi H, Fallara G, Montorsi F, Necchi A, Galsky MD. Adjuvant immunotherapy in patients with high-risk muscle-invasive urothelial carcinoma: The potential impact of informative censoring. Cancer. 2022 Aug 1;128(15):2892-2897. doi: 10.1002/cncr.34255. Epub 2022 May 12. PMID: 35553053 |
| Cha E, Mathis NJ, Joshi H, Sharma S, Zinovoy M, Ru M, Cahlon O, Gillespie EF, Marshall DC. Bias in Patient Experience Scores in Radiation Oncology: A Multicenter Retrospective Analysis. J Am Coll Radiol. 2022 Apr;19(4):542-551. doi: 10.1016/j.jacr.2022.01.013. Epub 2022 Mar 2. PMID: 35247326; PMCID: PMC9017791. |
| Veluswamy R, Hu L, Smith C, Ji J, Wang X, Wisnivesky J, Morillo J, Kale MS. Immunotherapy Outcomes in Individuals With Non-Small Cell Lung Cancer and Poor Performance Status. JNCI Cancer Spectr. 2022 Mar 2;6(2):pkac013. doi: 10.1093/jncics/pkac013. PMID: 35603847; PMCID: PMC8921740. |
| Rodriguez-Tirado C, Kale N, Carlini MJ, Shrivastava N, Rodrigues AA, Khalil BD, Bravo-Cordero JJ, Hong Y, Alexander M, Ji J, Behbod F, Sosa MS. NR2F1 Is a Barrier to Dissemination of Early-Stage Breast Cancer Cells. Cancer Res. 2022 Jun 15;82(12):2313-2326. doi: 0.1158/0008-5472.CAN-21-4145. PMID: 35471456; PMCID: PMC9203932. |
| Hu L, Zou J, Gu C, Ji J, Lopez M, Kale M. A FLEXIBLE SENSITIVITY ANALYSIS APPROACH FOR UNMEASURED CONFOUNDING WITH MULTIPLE TREATMENTS AND A BINARY OUTCOME WITH APPLICATION TO SEER-MEDICARE LUNG CANCER DATA. Ann Appl Stat. 2022 Jun;16(2):1014-1037. doi: 10.1214/21-aoas1530. Epub 2022 Jun 13. PMID: 36644682 PMCID: PMC9835106 |
| Niu L, Hu L, Li Y, Liu B. Correlates of cancer prevalence across census tracts in the United States: A Bayesian machine learning approach. Spat Spatiotemporal Epidemiol. 2022 Aug;42:100522. doi: 10.1016/j.sste.2022.100522. Epub 2022 May 27. PMID: 35934328. |
| Li L, Hu L, Ji J, Mckendrick K, Moreno J, Kelley AS, Mazumdar M, Aldridge M. Determinants of Total End-of-Life Health Care Costs of Medicare Beneficiaries: A Quantile Regression Forests Analysis. J Gerontol A Biol Sci Med Sci. 2022 May 5;77(5):1065-1071. doi: 10.1093/gerona/glab176. PMID: 34153101; PMCID: PMC9071433. |
| Li L, Zhan S, Naasan G, Ornstein KA, Taioli E, Mazumdar M, Jebakumar J, McCardle K, Liu B. Time trends in cancer and dementia related hospital admissions among Medicare fee-for-service population, 2013-2018. J GeriatrOncol. 2022 Sep;13(7):1058-1061. doi: 10.1016/j.jgo.2022.04.012. Epub 2022 May 3. PMID: 35514016. |
| Mazor MB, Li L, Morillo J, Allen OS, Wisnivesky JP, Smith CB. Disparities in Supportive Care Needs Over Time Between Racial and Ethnic Minority and Non- Minority Patients With Advanced Lung Cancer. J Pain Symptom Manage. 2022 Apr;63(4):563-571. doi: 10.1016/j.jpainsymman.2021.12.007. Epub 2022 Jan 11. PMID: 35031503; PMCID: PMC9336182. |
| LeBlanc M, Rueegg CS, Bekiroğlu N, Esterhuizen TM, Fagerland MW, Falk RS, Frøslie KF, Graf E, Heinze G, Held U, Holst R, Lange T, Mazumdar M, Myrberg IH, Posch M, Sergeant JC, Vach W, Vance EA, Weedon-Fekjaer H, Zucknick M. Statistical advising: Professional development opportunities for the biostatistician. Stat Med. 2022 Feb 28;41(5):847-859. doi: 10.1002/sim.9290. PMID: 35194815; PMCID: PMC9303234. |
| Rippel N, Tremblay D, Zubizarreta N, Podoltsev N, Gotlib J, Heaney M, Kuykendall A, O’Connell C, Shammo JM, Fleischman A, Kremyanskaya M, Hoffman R, Mesa R, Yacoub A, Mascarenhas J. Anagrelide for platelet-directed cytoreduction in polycythemia vera: Insights into utility and safety outcomes from a large multi-center database. Leuk Res. 2022 Aug;119:106903. doi: 10.1016/j.leukres.2022.106903. Epub 2022 Jun 16. PMID: 35717689. |
| Nehlsen A, Agarwal P, Mazumdar M, Dutta P, Goldstein NE, Dharmarajan KV. Impact of radiotherapy on daily function among older adults living with advanced cancer (RT impact on function in advanced cancer). J Geriatr Oncol. 2022 Jan;13(1):46-52. doi: 10.1016/j.jgo.2021.07.007. Epub 2021 Aug 3. PMID: 34362714; PMCID: PMC9044675. |
| Wolf A, Laskey D, Yip R, Beasley MB, Yankelevitz DF, Henschke CI; IELCART Investigators. Measuring the margin distance in pulmonary wedge resection. J Surg Oncol. 2022 Dec;126(7):1350-1358. doi: 10.1002/jso.27053. Epub 2022 Aug 17. PMID: 35975701. |
| Song KJ, Yip R, Chung M, Cai Q, Zhu Y, Singh A, Lewis EE, Yankelevitz D, Taioli E, Henschke C, Flores R; Initiative for Early Lung Cancer Research on Treatment and International Early Lung Cancer Action Program Investigators. New or enlarging hiatal hernias after thoracic surgery for early lung cancer. JTCVS Open. 2022 Feb 23;10:415-423. doi: 10.1016/j.xjon.2022.02.013. PMID: 36004265; PMCID: PMC9390567. |
| Schwartz RM, Yip R, You N, Gillezeau C, Song K, Yankelevitz DF, Taioli E, Henschke CI, Flores RM; IELCART Investigators. Early-Stage Lung Cancer Patients’ Perceptions of Presurgical Discussions. MDM Policy Pract. 2022 Mar 21;7(1):23814683221085570. doi: 0.1177/23814683221085570. PMID: 35341091; PMCID: PMC8941700. |
| Nicastri DG, Chan H, You N, Yip R, Ray K, Taioli E, Yankelevitz DF, Henschke CI, Flores RM; IELCART Investigators. Effects of Smoking, Obesity, and Pulmonary Function on Home Oxygen Use after Curative Lung Cancer Surgery. Ann Am Thorac Soc. 2022 Mar;19(3):442- 50. doi: 10.1513/AnnalsATS.202103-231OC. PMID: 34699344 |
| Cai Q, Triphuridet N, Zhu Y, You N, Yip R, Yankelevitz DF, Henschke CI. Bronchiectasis in Low-Dose CT Screening for Lung Cancer. Radiology. 2022 Aug;304(2):437-447. doi: 10.1148/radiol.212547. Epub 2022 Apr 19. PMID: 35438565. |
| Adler S, Yip R, Chan H, Cai Q, Zhu Y, Triphuridet N, Kaufman A, Taioli E, Flores R, Henschke CI, Yankelevitz DF; IELCART Investigators. Comparison of lung cancer aggressiveness in patients who never smoked compared to those who smoked. Lung Cancer. 2022 sep;171:90-96. doi: 10.1016/j.lungcan.2022.07.002. Epub 2022 Jul 15. PMID: 35932521. |
| Wagaskar VG, Lantz A, Sobotka S, Ratnani P, Parekh S, Falagario UG, Li L, Lewis S, Haines Iii K, Punnen S, Wiklund P, Tewari A. Development and External Validation of a Prediction Model to Identify Candidates for Prostate Biopsy. Urol J. 2022 Nov 8;19(5):379-385. doi: 10.22037/uj.v18i.6852. PMID: 34978065. |
| Ratnani P, Dovey Z, Parekh S, Sobotka S, Shukla D, Davis A, Roshandel R, Wagaskar V, Jambor I, Lundon DJ, Wiklund P, Kyprianou N, Menon M, Tewari A. Prostate MRI percentage tumor involvement or “PI-RADS percent” as a predictor of adverse surgical pathology. Prostate. 2022 Jun;82(9):970-983. doi:10.1002/pros.24344. Epub 2022 Apr 19. PMID: 35437769. |
| Parekh S, Ratnani P, Falagario U, Lundon D, Kewlani D, Nasri J, Dovey Z, Stroumbakis D, Ranti D, Grauer R, Sobotka S, Pedraza A, Wagaskar V, Mistry L, Jambor I, Lantz A, Ettala O, Stabile A, Taimen P, Aronen HJ, Knaapila J, Perez IM, Gandaglia G, Martini A, Picker W, Haug E, Cormio L, Nordström T, Briganti A, Boström PJ, Carrieri G, Haines K, Gorin MA, Wiklund P, Menon M, Tewari A. The Mount Sinai Prebiopsy Risk Calculator for Predicting any Prostate Cancer and Clinically Significant Prostate Cancer: Development of a Risk Predictive Tool and Validation with Advanced Neural Networking, Prostate Magnetic Resonance Imaging Outcome Database, and European Randomized Study of Screening for Prostate Cancer Risk Calculator. Eur Urol Open Sci. 2022 May 20;41:45-54. doi: 10.1016/j.euros.2022.04.017. PMID: 35813258; PMCID: PMC9257660. |
| Chakravarty D, Ratnani P, Huang L, Dovey Z, Sobotka S, Berryhill R, Merisaari H, Al Shaarani M, Rai R, Jambor I, Yadav KK, Mittan S, Parekh S, Kodysh J, Wagaskar V, Brody R, Cordon-Cardo C, Rykunov D, Reva B, Davicioni E, Wiklund P, Bhardwaj N, Nair SS, Tewari AK. Association between Incidental Pelvic Inflammation and Aggressive Prostate Cancer. Cancers (Basel). 2022 May 31;14(11):2734. doi: 10.3390/cancers14112734. PMID: 35681714; PMCID: PMC9179284. |
| Beksac AT, Ratnani P, Dovey Z, Parekh S, Falagario U, Roshandel R, Sobotka S, Kewlani D, Davis A, Weil R, Bashorun H, Jambor I, Lewis S, Haines K, Tewari AK. Unified model involving genomics, magnetic resonance imaging and prostate-specific antigen density outperforms individual co-variables at predicting biopsy upgrading in patients on active surveillance for low risk prostate cancer. Cancer Rep (Hoboken). 2022 Mar;5(3):e1492. doi: 10.1002/cnr2.1492. Epub 2021 Dec 20. PMID: 34931468; PMCID: PMC8955055. |
| Rosenbaum CA, Özbek U, Sanchez L, Lagdameo J, Abrahams A, Hassoun H, Lahoud O, Niesvizky R, Landau HJ, Osman K. Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis. Blood Adv. 2022 Sep 27;6(18):5436-5439. doi: 10.1182/bloodadvances.2022007826. PMID: 35858371; PMCID: PMC9631711. |
| Mondal C, Gacha-Garay MJ, Larkin KA, Adikes RC, Di Martino JS, Chien CC, Fraser M, Eni-Aganga I, Agullo-Pascual E, Cialowicz K, Ozbek U, Naba A, Gaitas A, Fu TM, Upadhyayula S, Betzig E, Matus DQ, Martin BL, Bravo-Cordero JJ. A proliferative to invasive switch is mediated by srGAP1 downregulation through the activation of TGF-β2 signaling. Cell Rep. 2022 Sep 20;40(12):111358. doi: 10.1016/j.celrep.2022.111358. PMID: 36130489; PMCID: PMC9596226. |
| Etra A, Gergoudis S, Morales G, Spyrou N, Shah J, Kowalyk S, Ayuk F, Baez J, Chanswangphuwana C, Chen YB, Choe H, DeFilipp Z, Gandhi I, Hexner E, Hogan WJ, Holler E, Kapoor U, Kitko CL, Kraus S, Lin JY, Al Malki M, Merli P, Pawarode A, Pulsipher MA, Qayed M, Reshef R, Rösler W, Schechter T, Van Hyfte G, Weber D, Wölfl M, Young R, Özbek U, Ferrara JLM, Levine JE. Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification. Blood Adv. 2022 Jun 28;6(12):3707-3715. doi: 10.1182/bloodadvances.2022007296. PMID: 35443021; PMCID: PMC9631548. |
| Buckstein M, Kim E, Özbek U, Tabrizian P, Gunasekaran G, Facciuto M, Rosenzweig K, Llovet JM, Schwartz M. Combination Transarterial Chemoembolization and Stereotactic Body Radiation Therapy for Unresectable Single Large Hepatocellular Carcinoma: Results From a Prospective Phase 2 Trial. Int J Radiat Oncol Biol Phys. 2022 Oct 1;114(2):221-230. doi: 10.1016/j.ijrobp.2022.05.021. Epub 2022 May 26. PMID: 35643250. |
| Andacoglu O, Sabisch E, Malamutmann E, Ozbek U, Emre A, Tokat Y, Oezcelik A. Multi-center living liver donor quality of life survey up to 20 years after donor hepatectomy and association with surgical outcomes. HPB (Oxford). 2022 Nov;24(11):1975-1979. doi: 10.1016/j.hpb.2022.06.007. Epub 2022 Jun 24. PMID: 35817693. |
| Mortha A, Remark R, Del Valle DM, Chuang LS, Chai Z, Alves I, Azevedo C, Gaifem J, Martin J, Petralia F, Tuballes K, Barcessat V, Tai SL, Huang HH, Laface I, Jerez YA, Boschetti G, Villaverde N, Wang MD, Korie UM, Murray J, Choung RS, Sato T, Laird RM, Plevy S, Rahman A, Torres J, Porter C, Riddle MS, Kenigsberg E, Pinho SS, Cho JH, Merad M, Colombel JF, Gnjatic S. Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn’s Disease. Gastroenterology. 2022 Sep;163(3):659-670. doi: 10.1053/j.gastro.2022.05.029. Epub 2022 May 24. PMID: 35623454. |
| Song X, Ru M, Steinsnyder Z, Tkachuk K, Kopp RP, Sullivan J, Gümüş ZH, Offit K, Joseph V, Klein RJ. SNPs at SMG7 Associated with Time from Biochemical Recurrence to Prostate Cancer Death. Cancer Epidemiol Biomarkers Prev. 2022 Jul 1;31(7):1466-1472. doi: 10.1158/1055-9965.EPI-22-0053. PMID: 35511739; PMCID: PMC9250608. |
| Marron TU, Galsky MD, Taouli B, Fiel MI, Ward S, Kim E, Yankelevitz D, Doroshow D, Guttman-Yassky E, Ungar B, Mehandru S, Golas BJ, Labow D, Sfakianos J, Nair SS, Chakravarty D, Buckstein M, Song X, Kenigsberg E, Gnjatic S, Brown BD, Sparano J, Tewari A, Schwartz , Bhardwaj N, Merad M. Author Correction: Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery. Nat Med. 2022 Aug;28(8):1723. doi: 10.1038/s41591-022-01948-3. Erratum for: Nat Med. 2022 Apr;28(4):626-629. PMID: 35851878. |
| Alves da Silva PH, Xing S, Kotini AG, Papapetrou EP, Song X, Wucherpfennig KW, Mascarenhas J, Ferrari de Andrade L. MICA/B antibody induces macrophage- mediated immunity against acute myeloid leukemia. Blood. 2022 Jan 13;139(2):205-216. doi: 0.1182/blood.2021011619. PMID: 34359073; PMCID: PMC8777466. |
| Cedillo G, George MC, Deshpande R, Benn EKT, Navis A, Nmashie A, Siddiqui A, Mueller BR, Chikamoto Y, Weiss L, Scherer M, Kamler A, Aberg JA, Vickrey BG, Bryan A, Horn B, Starkweather A, Fisher J, Robinson-Papp J. Toward Safer Opioid Prescribing in HIV care (TOWER): a mixed-methods, cluster-randomized trial. Addict Sci Clin Pract. 2022 May 16;17(1):28. doi: 10.1186/s13722-022-00311-8. PMID: 35578356; PMCID: PMC9108346. |
| Zewde MG, Alpert N, Taioli E. Methodological Considerations on COVID-19 Mortality in Cancer Patients: A Systematic Review and Meta-Analysis. JNCI Cancer Spectr. 2022 Sep 1;6(5):pkac063. doi: 10.1093/jncics/pkac063. PMID: 36047915; PMCID: PMC9619849. |
| Yu H, Tuminello S, Alpert N, van Gerwen M, Yoo S, Mulholland DJ, Aaronson SA, Donovan M, Oh WK, Gong Y, Wang L, Zhu J, Taioli E. Global DNA methylation of WTC prostate cancer tissues show signature differences compared to non-exposed cases. Carcinogenesis. 2022 Jun 27;43(6):528-537. doi: 10.1093/carcin/bgac025. PMID: 35239955; PMCID: PMC9234756. |
| van Gerwen M, Alsen M, Alpert N, Sinclair C, Taioli E. Trends for In- and Outpatient Thyroid Cancer Surgery in Older Adults in New York State, 2007-2017. J Surg Res. 2022 May;273:64-70. doi: 10.1016/j.jss.2021.12.008. Epub 2022 Jan 11. PMID: 35030431. |
| van Gerwen M, Cooke PV, Alpert N, Mols F, Genden E, Schwartz RM. Patient-reported outcomes following total thyroidectomy and lobectomy in thyroid cancer survivors: an analysis of the PROFILES Registry data. Support Care Cancer. 2022 Jan;30(1):687-693. doi: 10.1007/s00520-021-06355-x. Epub 2021 Aug 7. PMID: 34363111. |
| Tuminello S, Alpert N, Veluswamy RR, Kumar A, Gomez JE, Flores R, Taioli E. Modulation of chemoimmunotherapy efficacy in non-small cell lung cancer by sex and histology: a real-world, patient-level analysis. BMC Cancer. 2022 Jan 19;22(1):80. doi: 10.1186/s12885-022-09187-y. PMID: 35045806; PMCID: PMC8767728 |
| Patel PB, Alpert N, Taioli E, Flores R. Disparities in clinical and demographic characteristics among Asian/Pacific Islander and Non-Hispanic White newly diagnosed lung cancer patients. Cancer Causes Control. 2022 Apr;33(4):547-557. doi: 10.1007/s10552-021-01548-5. Epub 2022 Jan 19. PMID: 35043281. |
| Patel K, Alpert N, Tuminello S, Taioli E. Association of Personal Characteristics and Effectiveness of Immunotherapy in Late-Stage Non-Small Cell Lung Cancer: A Systematic Review. JNCI Cancer Spectr. 2022 Mar 2;6(2):pkac015. doi: 10.1093/jncics/pkac015. PMID: 35603843; PMCID: PMC8935137. |
| Liu B, Kent EE, Dionne-Odom JN, Alpert N, Ornstein KA. A national profile of health-focused caregiving activities prior to a new cancer diagnosis. J Geriatr Oncol. 2022 May;13(4):454-461. doi: 10.1016/j.jgo.2021.11.010. Epub 2021 Nov 18. PMID: 34801426; PMCID: PMC9058151. |
| Lazar JF, Adnan SM, Alpert N, Joshi S, Abbas AE, Bhora FY, Taioli E, Bakhos CT. The Scan, the Needle, or the Knife? National Trends in Diagnosing Stage I Lung Cancer. Innovations (Phila). 2022 Nov-Dec;17(6):538-547. doi: 10.1177/15569845221140399. Epub 2022 Dec 20. PMID: 36539948. |
| Flores R, Alpert N, McCardle K, Taioli E. Shift in lung cancer stage at diagnosis during the COVID-19 pandemic in New York City. Transl Lung Cancer Res. 2022 Jul;11(7):1514-1516. doi: 10.21037/tlcr-22-191. PMID: 35958333; PMCID: PMC9359952. |
| Chen H, Fan S, Stone J, Thompson DJ, Douglas J, Li S, Scott C, Bolla MK, Wang Q, Dennis J, Michailidou K, Li C, Peters U, Hopper JL, Southey MC, Nguyen-Dumont T, Nguyen TL, Fasching PA, Behrens A, Cadby G, Murphy RA, Aronson K, Howell A, Astley S, Couch F, Olson J, Milne RL, Giles GG, Haiman CA, Maskarinec G, Winham S, John EM, Kurian A, Eliassen H, Andrulis I, Evans DG, Newman WG, Hall P, Czene K, Swerdlow A, Jones M, Pollan M, Fernandez-Navarro P, McConnell DS, Kristensen VN; NBCS Investigators; Rothstein JH, Wang P, Habel LA, Sieh W, Dunning AM, Pharoah PDP, Easton DF, Gierach GL, Tamimi RM, Vachon CM, Lindström S. Genome-wide and transcriptome-wide association studies of mammographic densityphenotypes reveal novel loci. Breast Cancer Res. 2022 Apr 12;24(1):27. doi:10.1186/s13058-022-01524-0. PMID: 35414113; PMCID: PMC9006574. |
| Overbey, J. R., Cheung, Y. K., & Bagiella, E. (2022). Integrating non-concurrent controls in the analyses of late-entry experimental arms in multi-arm trials with a shared control group in the presence of parameter drift. Contemporary clinical trials, 123, 106972. https://doi.org/10.1016/j.cct.2022.106972 |
| Vietti Violi N, Gnerre J, Law A, Hectors S, Bane O, Doucette J, Abboud G, Kim E, Schwartz M, Fiel MI, Taouli B. Assessment of HCC response to Yttrium-90 radioembolization with gadoxetate disodium MRI: correlation with histopathology. Eur Radiol. 2022 Sep;32(9):6493-6503. doi: 10.1007/s00330-022-08732-4. Epub 2022 Apr 5. PMID: 35380226. |
| Lewis S, Ganti A, Argiriadi P, Rosen A, Hectors S, Semaan S, Song C, Peti S, Segall M, George K, Jaikaran V, Villa S, Kestenbaum D, Voutsinas N, Doucette J, Tewari A, Rastinehad AR, Taouli B. Prostate MRI using a rigid two-channel phased-array endorectal coil: comparison with phased array coil acquisition at 3 T. Cancer Imaging. 2022 Mar 16;22(1):15. doi: 10.1186/s40644-022-00453-7. PMID: 35296357; PMCID: PMC8925156. |
| Brewer MJ, Doucette JT, Bar-Mashiah A, Glickman JW, Kessel E, Aronson A, Lucas AL. Glycemic Changes and Weight Loss Precede Pancreatic Ductal Adenocarcinoma by up to 3 Years in a Diverse Population. Clin Gastroenterol Hepatol. 2022 May;20(5):1105-1111.e2. doi: 10.1016/j.cgh.2021.07.046. Epub 2021 Aug 3. PMID: 34358720. |
| Zhou M, Bressler T, Weinberg A, Snow A. Lessons learned from a social worker’s approach to advance care planning discussions with Chinese-immigrant oncology outpatients. J Psychosoc Oncol. 2022 Jul 26:1-9. doi: 10.1080/07347332.2022.2103486. Epub ahead of print. PMID: 35880458. |
2021
| Publication Reference |
| Frydman JL, Berkalieva A, Liu B, Scarborough BM, Mazumdar M, Smith CB. Telemedicine Utilization in the Ambulatory Palliative Care Setting: Are There Disparities? J Pain Symptom Manage. 2021 Oct 10:S0885-3924(21)00564-9. doi: 10.1016/j.jpainsymman.2021.09.019. Epub ahead of print. PMID: 34644615. |
| Kang SK, Mali RD, Prabhu V, Ferket BS, Loeb S. Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness. Radiology. 2021 Sep;300(3):594-604. doi: 10.1148/radiol.2021204321. Epub 2021 Jul 13. Erratum in: Radiology. 2021 Oct;301(1):E380. PMID: 34254851; PMCID:PMC8409107. |
| Marqueen KE, Kim E, Ang C, Mazumdar M, Buckstein M, Ferket BS. Cost- Effectiveness Analysis of Selective Internal Radiotherapy With Yttrium-90 Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma. JCO Oncol Pract. 2021 Feb;17(2):e266-e277. doi: 10.1200/OP.20.00443. Epub 2021 Jan 8. PMID: 33417490;PMCID: PMC8258013. |
| Alberty-Oller JJ, Reyes S, Moshier E, Ru M, Weltz S, Santos A, Pisapati K, Port E, Jaffer S. Does previous history of cancer or atypia predict histologic upgrade for pure intraductal papillomas diagnosed via core biopsy? A study of 490 cases at a single institution. Cancer Rep (Hoboken). 2021 Nov 2:e1481. doi: 10.1002/cnr2.1481. Epub ahead of print. PMID: 34729946. |
| Berger NF, Zimmerman BS, Tharakan S, Suchman K, Cascetta KP, Blanter J, Moshier E, Ru M, Jaffer S, Tiersten A. Secondary Invasive Breast Events among Patients with Hormone-Positive Breast Cancer and High-Risk Oncotype DX Recurrence Scores 26-30 and ≥31. Oncology. 2021;99(11):699-702. doi: 10.1159/000517843. Epub 2021 Aug 23. PMID: 34425579. |
| Hobbs G, Cimen Bozkus C, Moshier E, Dougherty M, Bar-Natan M, Sandy L, Johnson K, Foster JE, Som T, Macrae M, Marble H, Salama M, El Jamal SM, Zubizarreta N, Wadleigh M, Stone R, Bhardwaj N, Iancu-Rubin C, Mascarenhas J. PD-1 inhibition in advanced myeloproliferative neoplasms. Blood Adv. 2021 Dec 14;5(23):5086-5097. doi: 10.1182/bloodadvances.2021005491. PMID: 34581778. |
| Marqueen KE, Moshier E, Buckstein M, Ang C. Neoadjuvant therapy for gastrointestinal stromal tumors: A propensity score-weighted analysis. Int J Cancer. 2021 Jul 1;149(1):177-185. doi: 10.1002/ijc.33536. Epub 2021 Mar 19. PMID: 33634858. |
| Mouhieddine TH, Hieulle J, Moshier E, Richard S, Richter J, Cho HJ, Parekh S, Barlogie B, Chari A, Jagannath S, Madduri D. Treatment Bridging With a 28-Day Metronomic Therapy (Metro-28) for Relapsed Refractory Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2021 Sep 11:S2152-2650(21)02033-4. doi: 10.1016/j.clml.2021.09.004. Epub ahead of print. PMID: 34670732. |
| Nehlsen AD, Sindhu KK, Moshier E, Richter J, Richard S, Chari A, Sanchez L, Parekh S, Cho HJ, Jagannath S, Dharmarajan K. The Safety and Efficacy of Radiation Therapy with Concurrent Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin-Based Systemic Therapy for Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2021 Sep 24:S2152-2650(21)02045-0. doi: 10.1016/j.clml.2021.09.015. Epub ahead of print. PMID: 34736880. |
| Nehlsen AD, Sindhu KK, Moshier E, Sfakianos JP, Stock RG. The impact of a rectal hydrogel spacer on dosimetric and toxicity outcomes among patients undergoing combination therapy with external beam radiotherapy and low-dose-rate brachytherapy. Brachytherapy. 2021 Mar-Apr;20(2):296-301. doi: 10.1016/j.brachy.2020.09.018. Epub 2020 Nov 13. PMID: 33199175. |
| Ronner L, Venugopal S, Moshier E, Mascarenhas J. Improving the investigative approach to polycythaemia vera: a critical assessment of current evidence and vision for the future. Lancet Haematol. 2021 Aug;8(8):e605-e612. doi: 10.1016/S2352-3026(21)00171-X. PMID: 34329580. |
| Zeidman M, Schmidt H, Alberty-Oller JJ, Pisapati KV, Ahn S, Mazumdar M, Ru M, Moshier E, Port E. Trends in neoadjuvant chemotherapy versus surgery-first in stage I HER2-positive breast cancer patients in the National Cancer DataBase (NCDB). Breast Cancer Res Treat. 2021 May;187(1):177-185. doi: 10.1007/s10549-020-06041-2. Epub 2021 Jan 4. PMID: 33392839. |
| Zhou S, Tremblay D, Hoffman R, Kremyanskaya M, Najfeld V, Li L, Moshier E, Mascarenhas J. Clinical Benefit Derived from Decitabine Therapy for Advanced Phases of Myeloproliferative Neoplasms. Acta Haematol. 2021;144(1):48-57. doi: 10.1159/000506146. Epub 2020 Mar 11. PMID: 32160610; PMCID: PMC7773003. |
| Zimmerman BS, Seidman D, Cascetta KP, Ru M, Moshier E, Tiersten A. Prognostic Factors and Survival Outcomes among Patients with Breast Cancer and Brain Metastases at Diagnosis: A National Cancer Database Analysis. Oncology. 2021;99(5):280-291. doi: 10.1159/000512212. Epub 2021 Mar 2. PMID: 33652435. |
| Joshi H, Lin S, Fei K, Renteria AS, Jacobs H, Mazumdar M, Jagannath S, Bickell NA. Multiple myeloma, race, insurance and treatment. Cancer Epidemiol. 2021 Aug;73:101974. doi: 10.1016/j.canep.2021.101974. Epub 2021 Jul 6. PMID: 34243048; PMCID: PMC8552452. |
| Poeran J, Cho LD, Wilson L, Zhong H, Mazumdar M, Liu J, Memtsoudis SG. Pre-existing Disparities and Potential Implications for the Rapid Expansion of Telemedicine in Response to the Coronavirus Disease 2019 Pandemic. Med Care. 2021 Aug 1;59(8):694-698. doi: 10.1097/MLR.0000000000001585. PMID: 34054024; PMCID: PMC8263094. |
| Poeran J. CORR Insights®: Has the Affordable Care Act Been Associated with Increased Insurance Coverage and Early-stage Diagnoses of Bone and Soft-tissue Sarcomas in Adults? Clin Orthop Relat Res. 2021 Mar 1;479(3):503-505. doi: 10.1097/CORR.0000000000001483. PMID: 32947285; PMCID: PMC7899539. |
| Gordon NT, Alberty-Oller JJ, Fei K, Greco G, Gallagher EJ, LeRoith D, Feldman SM, Killilea B, Boolbol SK, Choi L, Friedman N, Pilewskie M, Port E, Tiersten A, Bickell NA. Association of Insulin Resistance and Higher Oncotype DX™ Recurrence Score. Ann Surg Oncol. 2021 Oct;28(11):5941-5947. doi: 10.1245/s10434-021-09748-8. Epub 2021 Apr 3. PMID: 33813671. |
| Franzosa E, Gorbenko K, Brody AA, Leff B, Ritchie CS, Kinosian B, Ornstein KA, Federman AD. “At Home, with Care”: Lessons from New York City Home-based Primary Care Practices Managing COVID-19. J Am Geriatr Soc. 2021 Feb;69(2):300-306. doi: 10.1111/jgs.16952. Epub 2020 Nov 20. PMID: 33179761. |
| Hu L, Ji J, Li F. Estimating heterogeneous survival treatment effect in observational data using machine learning. Stat Med. 2021 Sep 20;40(21):4691-4713. doi: 10.1002/sim.9090. Epub 2021 Jun 10. PMID: 34114252. |
| Hu L, Joyce Lin JY, Ji J. Variable selection with missing data in both covariates and outcomes: Imputation and machine learning. Stat Methods Med Res. 2021 Dec;30(12):2651-2671. doi: 10.1177/09622802211046385. Epub 2021 Oct 25. PMID: 34696650. |
| Hu L, Lin JY (Joyce), Sigel K, Kale M. Estimating heterogeneous survival treatment effects of lung cancer screening approaches: A causal machine learning analysis. Ann Epidemiol. 2021 Oct;62:36-42. doi: 10.1016/j.annepidem.2021.06.008. Epub 2021 Jun 23. PMID: 34157399; PMCID: PMC8463451. |
| Li L, Cuerden MS, Liu B, Shariff S, Jain AK, Mazumdar M. Three Statistical Approaches for Assessment of Intervention Effects: A Primer for Practitioners. Risk Manag Healthc Policy. 2021 Feb 22;14:757-770. doi: 10.2147/RMHP.S275831. PMID: 33654443; PMCID: PMC7910529. |
| Li L, Hu L, Ji J, Mckendrick K, Moreno J, Kelley AS, Mazumdar M, Aldridge M. Determinants of total end-of-life healthcare costs of Medicare beneficiaries: A quantile regression forests analysis. J Gerontol A Biol Sci Med Sci. 2021 Jun 21:glab176. doi: 10.1093/gerona/glab176. Epub ahead of print. PMID: 34153101. |
| Li L, Zhan S, Hu L, Wilson KM, Mazumdar M, Liu B. Examining the role of healthcare access in racial/ethnic disparities in receipt of provider-patient discussions about smoking: A latent class analysis. Prev Med. 2021 Jul;148:106584. doi: 10.1016/j.ypmed.2021.106584. Epub 2021 Apr 27. PMID: 33930432. |
| Liu B, Zhan S, Wilson KM, Mazumdar M, Li L. The Influence of Increasing Levels of Provider-Patient Discussion on Quit Behavior: An Instrumental Variable Analysis of a National Survey. Int J Environ Res Public Health. 2021 Apr 26;18(9):4593. doi: 10.3390/ijerph18094593. PMID: 33926078; PMCID: PMC8123707. |
| Caba Y, Dharmarajan K, Gillezeau C, Ornstein KA, Mazumdar M, Alpert N, Schwartz RM, Taioli E, Liu B. The Impact of Dementia on Cancer Treatment Decision-Making, Cancer Treatment, and Mortality: A Mixed Studies Review. JNCI Cancer Spectr. 2021 Jan 27;5(3):pkab002. doi: 10.1093/jncics/pkab002. PMID: 34056540; PMCID: PMC8152697. |
| Kihira S, Tsankova NM, Bauer A, Sakai Y, Mahmoudi K, Zubizarreta N, Houldsworth J, Khan F, Salamon N, Hormigo A, Nael K. Multiparametric MRI texture analysis in prediction of glioma biomarker status: added value of MR diffusion. Neurooncol Adv. 2021 Apr 8;3(1):vdab051. doi: 10.1093/noajnl/vdab051. PMID: 34056604; PMCID: PMC8156980. |
| Naymagon L, Tremblay D, Zubizarreta N, Moshier E, Mascarenhas J, Schiano T. Safety, Efficacy, and Long-Term Outcomes of Anticoagulation in Cirrhotic Portal Vein Thrombosis. Dig Dis Sci. 2021 Oct;66(10):3619-3629. doi: 10.1007/s10620-020-06695-4. Epub 2020 Nov 5. PMID: 33151401. |
| Naymagon L, Tremblay D, Zubizarreta N, Moshier E, Naymagon S, Mascarenhas J, Schiano T. The Natural History, Treatments, and Outcomes of Portal Vein Thrombosis in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2021 Jan 19;27(2):215-223. doi: 10.1093/ibd/izaa053. PMID: 32185400; PMCID: PMC8427727. |
| Shapiro CL, Zubizarreta N, Moshier E, Brockway JP, Mandeli J, Markham MJ, Kozlik MM, Crist S, Jacobsen PB. Quality Care in Survivorship: Lessons Learned From the ASCO Quality Oncology Practice Initiative. JCO Oncol Pract. 2021 Aug;17(8):e1170-e1180. doi: 10.1200/OP.21.00290. Epub 2021 Jul 20. PMID: 34283637; PMCID: PMC8360453. |
| Tremblay D, Ronner L, Podoltsev N, Gotlib J, Heaney M, Kuykendall A, O’Connell C, Shammo JM, Fleischman A, Mesa R, Yacoub A, Hoffman R, Moshier E, Zubizarreta N, Mascarenhas J. Ruxolitinib discontinuation in polycythemia vera: Patient characteristics, outcomes, and salvage strategies from a large multi- institutional database. Leuk Res. 2021 Oct;109:106629. doi: 10.1016/j.leukres.2021.106629. Epub 2021 May 27. PMID: 34082375. |
| Yip R, Jirapatnakul A, Hu M, Chen X, Han D, Ma T, Zhu Y, Salvatore MM, Margolies LR, Yankelevitz DF, Henschke CI. Added benefits of early detection of other diseases on low-dose CT screening. Transl Lung Cancer Res. 2021 Feb;10(2):1141-1153. doi: 10.21037/tlcr-20-746. PMID: 33718052; PMCID: PMC7947380. |
| Henschke CI, Yankelevitz DF, Jirapatnakul A, Yip R, Reccoppa V, Benjamin C, Llamo T, Williams A, Liu S, Max D, Aguayo SM, Morales P, Igel BJ, Abbaszadegan H, Fredricks PA, Garcia DP, Permana PA, Fawcett J, Sultan S, Murphy LA. Implementation of low-dose CT screening in two different health care systems: Mount Sinai Healthcare System and Phoenix VA Health Care System. Transl Lung Cancer Res. 2021 Feb;10(2):1064-1082. doi: 10.21037/tlcr-20-761. PMID: 33718045; PMCID: PMC7947390. |
| Jirapatnakul A, Yip R, Branch AD, Lewis S, Crane M, Yankelevitz DF, Henschke CI. Dose-response relationship between World Trade Center dust exposure and hepatic steatosis. Am J Ind Med. 2021 Oct;64(10):837-844. doi:10.1002/ajim.23269. Epub 2021 Jul 30. PMID: 34328231. |
| Nicastri D, Chan H, You N, Yip R, Ray K, Taioli E, Yankelevitz DF, Henschke CI, Flores RM. Effects of Smoking, Obesity, and Pulmonary Function on Home Oxygen Use after Curative Lung Cancer Surgery. Ann Am Thorac Soc. 2021 Oct 26. doi: 10.1513/AnnalsATS.202103-231OC. Epub ahead of print. PMID: 34699344. |
| Siddique M, Yip R, Henschke CI, Yankelevitz DF. PET standardized uptake values of primary lung cancer for comparison with tumor volume doubling times. Clin Imaging. 2021 May;73:146-150. doi: 10.1016/j.clinimag.2020.11.048. Epub 2020 Dec 3. PMID: 33418311. |
| Steiger D, Siddiqi MF, Yip R, Yankelevitz DF, Henschke CI; I-ELCAP investigators. The importance of low-dose CT screening to identify emphysema in asymptomatic participants with and without a prior diagnosis of COPD. Clin Imaging. 2021 Oct;78:136-141. doi: 10.1016/j.clinimag.2021.03.012. Epub 2021 Mar 20. PMID: 33799061. |
| Zhu Y, Cai Q, Wang Y, You N, Yip R, Lee DS, Taioli E, Flores R, Henschke CI, Yankelevitz DF. Pre-surgical assessment of mediastinal lymph node metastases in patients having ≥ 30 mm non-small-cell lung cancers. Lung Cancer. 2021 Nov;161:189-196. doi: 10.1016/j.lungcan.2021.09.013. Epub 2021 Sep 21. PMID: 34624614. |
| Zhu Y, Yip R, You N, Cai Q, Henschke CI, Yankelevitz DF; International Early Lung Cancer Action Program Investigators; International Early Lung Cancer Action Program Investigators. Characterization of Newly Detected Costal Pleura-attached Noncalcified Nodules at Annual Low-Dose CT Screenings. Radiology. 2021 Dec;301(3):724-731. doi: 10.1148/radiol.2021210807. Epub 2021 Sep 21. PMID: 34546130. |
| Pan D Ip A ***Zhan S Wasserman I Snyder DJ Agathis AZ Shamapant N Yang JY Pai A Mazumdar M Poor H. Pre-hospital antiplatelet medication use on COVID-19 disease severity. Heart Lung. 2021 May 27;50(5):618-621. doi: 10.1016/j.hrtlng.2021.04.010. Epub ahead of print. PMID: 34090177; PMCID: PMC8156906 |
| Zhong X, Cheng B, Wang X, Cheung YK. SMARTAR: an R package for designing and analyzing Sequential Multiple Assignment Randomized Trials. PeerJ. 2021 Jan 11;9:e10559. doi: 10.7717/peerj.10559. PMID: 33510969; PMCID: PMC7808267. |
| Bikkasani K, Qin Q, Zhong X, Lin J, Galsky MD, Oh WK, Tsao CK. Characterizing Prostate-Specific Antigen Levels at Death in Patients with Metastatic Castration-Resistant Prostate Cancer: Are We Underutilizing Imaging? Clin Genitourin Cancer. 2021 Dec;19(6):e346-e351. doi: 10.1016/j.clgc.2021.04.003. Epub 2021 Apr 20. PMID: 34011488. |
| Parikh AB, Zhong X, Mellgard G, Qin Q, Patel VG, Wang B, Alerasool P, Garcia P, Leiter A, Gallagher EJ, Clinton S, Mortazavi A, Monk P, Folefac E, Yin M, Yang Y, Galsky M, Oh WK, Tsao CK. Risk Factors for Emergency Room and Hospital Care Among Patients With Solid Tumors on Immune Checkpoint Inhibitor Therapy. Am J Clin Oncol. 2021 Mar 1;44(3):114-120. doi: 10.1097/COC.0000000000000793. PMID: 33417323; PMCID: PMC7902456. |
| Tharakan S, Zhong X, Galsky MD. The impact of the globalization of cancer clinical trials on the enrollment of Black patients. Cancer. 2021 Jul 1;127(13):2294-2301. doi: 10.1002/cncr.33463. Epub 2021 Mar 8. PMID: 33682111. |
| Bhalla S, Zhu H, Lin JY, Özbek U, Wilck EJ, Chang S, Chen X, Ward S, Harpaz N, Polydorides AD, Miller W, Fiel MI, Modica I, Fan W, Zeizafoun N, Ang C. Impact of pathological response after neoadjuvant chemotherapy on adjuvant therapy decisions and patient outcomes in gastrointestinal cancers. Cancer Rep (Hoboken). 2021 Dec;4(6):e1412. doi: 10.1002/cnr2.1412. Epub 2021 May 25. PMID: 34032391; PMCID: PMC8714550. |
| Dickstein DR, Egerman M, Monrose E, Varma A, Ozbek U, Sharma S, Liu JT, Gupta V, Posner MR, Misiukiewicz K, Miles BA, Genden E, Bakst RL. Treatment tolerability and outcomes in elderly patients with head and neck cancer. Head Neck. 2021 Mar;43(3):858-873. doi: 10.1002/hed.26548. Epub 2020 Dec 8. PMID: 33615611. |
| Jun T, Ozbek U, Dharmapuri S, Hardy-Abeloos C, Zhu H, Lin JY, Personeni N, Pressiani T, Nishida N, Lee PC, Lee CJ, Hildebrand H, Nimkar N, Paul S, Fessas P, Naeem M, Bettinger D, Khan U, Saeed A, Huang YH, Kudo M, Rimassa L, Marron TU, Pinato DJ, Ang C. Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma. Ther Adv Med Oncol. 2021 Apr 28;13:17588359211010937. doi: 10.1177/17588359211010937. PMID: 33995594; PMCID: PMC8107671. |
| Muhammed A, Fulgenzi CAM, Dharmapuri S, Pinter M, Balcar L, Scheiner B, Marron TU, Jun T, Saeed A, Hildebrand H, Muzaffar M, Navaid M, Naqash AR, Gampa A, Ozbek U, Lin JY, Perone Y, Vincenzi B, Silletta M, Pillai A, Wang Y, Khan U, Huang YH, Bettinger D, Abugabal YI, Kaseb A, Pressiani T, Personeni N, Rimassa L, Nishida N, Di Tommaso L, Kudo M, Vogel A, Mauri FA, Cortellini A, Sharma R, D’Alessio A, Ang C, Pinato DJ. The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma. Cancers (Basel). 2021 Dec 31;14(1):186. doi: 10.3390/cancers14010186. PMID: 35008350; PMCID: PMC8750517. |
| Pan D, Coltoff A, Ozbek U, Lin JY, Afshar S, Galitzeck Z, Steinberg A. Evaluating Race and Time to Transplantation in Multiple Myeloma: The Mount Sinai Hospital Experience. Clin Lymphoma Myeloma Leuk. 2021 Jul;21(7):439-443. doi: 10.1016/j.clml.2021.02.003. Epub 2021 Feb 16. PMID: 33757769. |
| Williams M, Özbek U, Lin JY, Ang C. A single-institutional analysis of racial disparities in clinicopathologic characteristics, treatment selections, and outcomes in advanced-stage pancreatic cancer patients. Ann Pancreat Cancer. 2021 Oct;4:7. doi: 10.21037/apc-21-5. Epub 2021 Oct 30. PMID: 34964042; PMCID: PMC8711781. |
| Zewde MG, Morales G, Gandhi I, Özbek U, Aguayo-Hiraldo P, Ayuk F, Baez J, Chanswangphuwana C, Choe H, DeFilipp Z, Etra A, Grupp S, Hexner EO, Hogan W, Javorniczky NR, Kasikis S, Kitko CL, Kowalyk S, Meedt E, Merli P, Nakamura R, Qayed M, Reshef R, Rösler W, Schechter T, Weber D, Wölfl M, Yanik G, Young R, Levine JE, Ferrara JLM, Chen YB. Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease. Transplant Cell Ther. 2021 Dec;27(12):988.e1-988.e7. doi: 10.1016/j.jtct.2021.08.021. Epub 2021 Aug 30. PMID: 34474163; PMCID: PMC8671218. |
| Bhalla S, Bakouny Z, Schmidt AL, Labaki C, Steinharter JA, Tremblay DA, Awad MM, Kessler AJ, Haddad RI, Evans M, Busser F, Wotman M, Curran CR, Zimmerman BS, Bouchard G, Jun T, Nuzzo PV, Qin Q, Hirsch L, Feld J, Kelleher KM, Seidman D, Huang HH, Anderson-Keightly HM, El Zarif T, Abou Alaiwi S, Rosenbloom TD, Stewart PS, Galsky MD, Choueiri TK, Doroshow DB. Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes study. Lung Cancer. 2021 Oct;160:78-83. doi: 10.1016/j.lungcan.2021.07.002. Epub 2021 Jul 16. PMID: 34461400; PMCID: PMC8284065. |
| Song X, Ji J, Reva B, Joshi H, Calinawan AP, Mazumdar M, Wisnivesky JP, Taioli E, Wang P, Veluswamy RR. Post-anticoagulant D-dimer is a highly prognostic biomarker of COVID-19 mortality. ERJ Open Res. 2021 Jul 5;7(3):00018-2021. doi: 10.1183/23120541.00018-2021. PMID: 34230883; PMCID: PMC7942219. |
| Ahuno ST, Doebley AL, Ahearn TU, Yarney J, Titiloye N, Hamel N, Adjei E, Clegg-Lamptey JN, Edusei L, Awuah B, Song X, Vanderpuye V, Abubakar M, Duggan M, Stover DG, Nyarko K, Bartlett JMS, Aitpillah F, Ansong D, Gardner KL, Boateng FA, Bowcock AM, Caldas C, Foulkes WD, Wiafe S, Wiafe-Addai B, Garcia-Closas M, Kwarteng A, Ha G, Figueroa JD, Polak P; Ghana Breast Health Study Team. Circulating tumor DNA is readily detectable among Ghanaian breast cancer patients supporting non-invasive cancer genomic studies in Africa. NPJ Precis Oncol. 2021 Sep 17;5(1):83. doi: 10.1038/s41698-021-00219-7. PMID: 34535742; PMCID: PMC8448727. |
| Huang C, Chen L, Savage SR, Eguez RV, Dou Y, Song X, Ji J, Yoo S, Zhou DC, Liang WW, Wendl M, Vats P, Carr SA, Mani DR, Zhang Z, Qian J, Chen XS, Pico AR, Wang P, Chinnaiyan AM, Ketchum KA, Kinsinger CR, Robles AI, An E, Hiltke T, Mesri M, Thiagarajan M, Weaver AM, Sikora AG, Lubiński J, Wierzbicka M, Wiznerowicz M, Satpathy S, Gillette MA, Miles G, Ellis MJ, Omenn GS, Rodriguez H, Boja ES, Dhanasekaran SM, Ding L, Nesvizhskii AI, El-Naggar AK, Chan DW, Zhang H, Zhang B; Clinical Proteomic Tumor Analysis Consortium. Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma. Cancer Cell. 2021 Mar 8;39(3):361-379.e16. doi: 10.1016/j.ccell.2020.12.007. Epub 2021 Jan 7. PMID: 33417831; PMCID: PMC7946781. |
| Satpathy S, Krug K, Jean Beltran PM, Savage SR, Petralia F, Krek A, Lei JT, Jaehnig EJ, Omelchenko T, Geffen Y, Bergstrom EJ, Stathias V, Christianson KE, Heiman DI, Cieslik MP, Cao S, Song X, Ji J, Liu W, Li K, Wen B, Li Y, Gümüş ZH, Selvan ME, Soundararajan R, Visal TH, Raso MG, Parra ER, Babur Ö, Vats P, Anand S, Schraink T, Cornwell M, Rodrigues FM, Zhu H, Mo CK, Zhang Y, da Veiga Leprevost F, Huang C, Chinnaiyan AM, Wyczalkowski MA, Omenn GS, Newton CJ, Schurer S, Ruggles KV, Fenyö D, Jewell SD, Thiagarajan M, Mesri M, Rodriguez H, Mani SA, Udeshi ND, Getz G, Suh J, Li QK, Hostetter G, Paik PK, Dhanasekaran SM, Govindan R, Ding L, Robles AI, Clauser KR, Nesvizhskii AI, Wang P, Carr SA, Zhang B, Mani DR, Gillette MA; Clinical Proteomic Tumor Analysis Consortium. A proteogenomic portrait of lung squamous cell carcinoma. Cell. 2021 Aug 5;184(16):4348-4371.e40. doi: 10.1016/j.cell.2021.07.016. PMID: 34358469; PMCID: PMC8475722. |
| Wang LB, Karpova A, Gritsenko MA, Kyle JE, Cao S, Li Y, Rykunov D, Song X, Ji J, Tsai CF, Petyuk VA, Moon J, Ma W, Chu RK, Weitz KK, Moore RJ, Monroe ME, Zhao R, Yang X, Yoo S, Krek A, Demopoulos A, Zhu H, Wyczalkowski MA, McMichael JF, Henderson BL, Lindgren CM, Boekweg H, Lu S, Baral J, Yao L, Stratton KG, Bramer LM, Zink E, Couvillion SP, Bloodsworth KJ, Satpathy S, Sieh W, Boca SM, Schürer S, Chen F, Wiznerowicz M, Ketchum KA, Boja ES, Kinsinger CR, Robles AI, Hiltke T, Thiagarajan M, Nesvizhskii AI, Zhang B, Mani DR, Ceccarelli M, Chen XS, Cottingham SL, Li QK, Kim AH, Fenyö D, Ruggles KV, Rodriguez H, Mesri M, Payne SH, Resnick AC, Wang P, Smith RD, Iavarone A, Chheda MG, Barnholtz-Sloan JS, Rodland KD, Liu T, Ding L; Clinical Proteomic Tumor Analysis Consortium. Proteogenomic and metabolomic characterization of human glioblastoma. Cancer Cell. 2021 Apr 12;39(4):509-528.e20. doi: 10.1016/j.ccell.2021.01.006. Epub 2021 Feb 11. PMID: 33577785; PMCID: PMC8044053. |
2020
| Publication Reference |
| Ferket BS, Veenstra DL. Economic value of exome sequencing for suspected monogenic disorders. Genet Med. 2020 Jun 30. doi: 10.1038/s41436-020-0888-0. Epub ahead of print. PMID: 32601385. |
| Vietti Violi N, Lewis S, Liao J, Hulkower M, Hernandez-Meza G, Smith K, Babb JS, Chin X, Song J, Said D, Kihira S, Sirlin CB, Reeder SB, Bashir MR, Fowler KJ, Ferket BS, Sigel K, Taouli B. Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening. Eur Radiol. 2020 Jun 25. doi: 10.1007/s00330-020-07014-1. Epub ahead of print. PMID: 32588209. |
| Zeidman M, Alberty-Oller JJ, Ru M, Pisapati KV, Moshier E, Ahn S, Mazumdar M, Port E, Schmidt H. Use of neoadjuvant versus adjuvant chemotherapy for hormone receptor-positive breast cancer: a National Cancer Database (NCDB) study. Breast Cancer Res Treat. 2020 Nov;184(1):203-212. doi: 10.1007/s10549-020-05809-w. Epub 2020 Aug 1. PMID: 32740807. |
| Coltoff A, Mesa R, Gotlib J, Shulman J, Rampal RK, Siwoski O, Yacoub A, Moliterno A, Yang A, Braunstein E, Gerds AT, Hobbs GS, Winton EF, Goel S, Wadleigh M, Tremblay D, Moshier E, Mascarenhas J. Real-World Outcomes of Ruxolitinib Treatment for Polycythemia Vera. Clin Lymphoma Myeloma Leuk. 2020 Oct;20(10):697-703.e1. doi: 10.1016/j.clml.2020.05.019. Epub 2020 May 29. PMID: 32624445. |
| Fuller R, Moshier E, Jacobs SE, Tremblay D, Lancman G, Coltoff A, Caro J, Mascarenhas J, Rana M. Practicing Antimicrobial Stewardship: De-Escalating Antibiotics in Patients With Acute Myeloid Leukemia and Neutropenic Fever. Open Forum Infect Dis. 2020 Apr 21;7(5):ofaa138. doi: 10.1093/ofid/ofaa138. PMID: 32420406; PMCID: PMC7216765. |
| Leng S, Moshier E, Tremblay D, Hu L, Biran N, Barman N, Parekh S, Cho H, Madduri D, Richter J, Barlogie B, Jagannath S, Chari A. Timing of Autologous Stem Cell Transplantation for Multiple Myeloma in the Era of Current Therapies. Clin Lymphoma Myeloma Leuk. 2020 Oct;20(10):e734-e751. doi: 10.1016/j.clml.2020.05.027. Epub 2020 Jun 7. PMID: 32660906. |
| Ronner L, Podoltsev N, Gotlib J, Heaney ML, Kuykendall AT, O’Connell C, Shammo J, Fleischman AG, Scherber RM, Mesa R, Yacoub A, Perkins C, Meckstroth S, Behlman L, Chiaramonte M, Salehi M, Ziadkhanpour K, Nguyen H, Siwoski O, Hung AK, Janania Martinez M, Nguyen J, Patel S, Kollipara R, Dave A, Randall M, Grant M, Harrison M, Fernandez Soto P, Tremblay D, Hoffman R, Moshier E, Mascarenhas J. Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis. Blood. 2020 May 7;135(19):1696-1703. doi: 10.1182/blood.2019003347. PMID: 32107559; PMCID: PMC7205813. |
| Sindhu KK, Leiter A, Moshier E, Lin JY, Carroll E, Brooks D, Shimol JB, Eisenberg E, Gallagher EJ, Stock RG, Galsky MD, Buckstein M. Durable disease control with local treatment for oligoprogression of metastatic solid tumors treated with immune checkpoint blockade. Cancer Treat Res Commun. 2020;25:100216. doi: 10.1016/j.ctarc.2020.100216. Epub 2020 Oct 8. PMID: 33049542. |
| Tremblay D, Vogel AS, Moshier E, Hoffman R, Kremyanskaya M, Zhou S, Schiano T, Mascarenhas J. Outcomes of splanchnic vein thrombosis in patients with myeloproliferative neoplasms in a single center experience. Eur J Haematol. 2020 Jan;104(1):72-73. doi: 10.1111/ejh.13335. Epub 2019 Oct 16. PMID: 31587352; PMCID: PMC7781435. |
| Winoker JS, Wajswol E, Falagario U, Maritini A, Moshier E, Voutsinas N, Knauer CJ, Sfakianos JP, Lewis SC, Taouli BA, Rastinehad AR. Transperineal Versus Transrectal Targeted Biopsy With Use of Electromagnetically-tracked MR/US Fusion Guidance Platform for the Detection of Clinically Significant Prostate Cancer. Urology. 2020 Dec;146:278-286. doi: 10.1016/j.urology.2020.07.072. Epub 2020 Sep 18. PMID: 32956688. |
| Zimmerman BS, Seidman D, Berger N, Cascetta KP, Nezolosky M, Trlica K, Ryncarz A, Keeton C, Moshier E, Tiersten A. Patient Perception of Telehealth Services for Breast and Gynecologic Oncology Care during the COVID-19 Pandemic: A Single Center Survey-based Study. J Breast Cancer. 2020 Oct 19;23(5):542-552. doi: 10.4048/jbc.2020.23.e56. PMID: 33154829; PMCID: PMC7604367. |
| DuHamel KN, Schofield EA, Villagra C, Sriphanlop P, Itzkowitz SH, Cotter G, Cohen N, Erwin DO, Winkel G, Thompson HS, Zauber AG, Jandorf LH. Promoting colonoscopy screening among low-income Latinos at average risk of colorectal cancer: A randomized clinical trial. Cancer. 2020 Feb 15;126(4):782-791. doi: 10.1002/cncr.32541. Epub 2019 Nov 19. PMID: 31742670; PMCID: PMC6992525. |
| Cheng FY, Joshi H, Tandon P, Freeman R, Reich DL, Mazumdar M, Kohli-Seth R, Levin M, Timsina P, Kia A. Using Machine Learning to Predict ICU Transfer in Hospitalized COVID-19 Patients. J Clin Med. 2020 Jun 1;9(6):1668. doi: 10.3390/jcm9061668. PMID: 32492874; PMCID: PMC7356638. |
| Kia A, Timsina P, Joshi HN, Klang E, Gupta RR, Freeman RM, Reich DL, Tomlinson MS, Dudley JT, Kohli-Seth R, Mazumdar M, Levin MA. MEWS++: Enhancing the Prediction of Clinical Deterioration in Admitted Patients through a Machine Learning Model. J Clin Med. 2020 Jan 27;9(2):343. doi: 10.3390/jcm9020343. PMID: 32012659; PMCID: PMC7073544. |
| Parchure P, Joshi H, Dharmarajan K, Freeman R, Reich DL, Mazumdar M, Timsina P, Kia A. Development and validation of a machine learning-based prediction model for near-term in-hospital mortality among patients with COVID-19. BMJ Support Palliat Care. 2020 Sep 22:bmjspcare-2020-002602. doi: 10.1136/bmjspcare-2020-002602. Epub ahead of print. PMID: 32963059. |
| Hughley R, Karlic R, Joshi H, Turnbull C, Foulkes WD, Polak P. Etiologic Index – A Case-Only Measure of <i>BRCA1/2</i>-Associated Cancer Risk. N Engl J Med. 2020 Jul 16;383(3):286-288. doi: 10.1056/NEJMc1913988. PMID: 32668122. |
| Haskins SC, Fiasconaro M, Wilson L, Poeran J, Liu J, Memtsoudis S. Ultrasound guidance for peripheral nerve blocks: an observational trend study of national data. Reg Anesth Pain Med. 2020 Feb 12:rapm-2019-101113. doi: 10.1136/rapm-2019-101113. Epub ahead of print. PMID: 32054667. |
| Pavlick A, Blazquez AB, Meseck M, Lattanzi M, Ott PA, Marron TU, Holman RM, Mandeli J, Salazar AM, McClain CB, Gimenez G, Balan S, Gnjatic S, Sabado RL, Bhardwaj N. Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma. Cancer Immunol Res. 2020 Jan;8(1):70-80. doi: 10.1158/2326-6066.CIR-19-0545. Epub 2019 Nov 7. PMID: 31699709; PMCID: PMC6946846. |
| Gallagher EJ, Fei K, Feldman SM, Port E, Friedman NB, Boolbol SK, Killelea B, Pilewskie M, Choi L, King T, Nayak A, Franco R, Cruz D, Antoniou IM, LeRoith D, Bickell NA. Insulin resistance contributes to racial disparities in breast cancer prognosis in US women. Breast Cancer Res. 2020 May 12;22(1):40. doi: 10.1186/s13058-020-01281-y. PMID: 32393319; PMCID: PMC7216707. |
| Holzner ML, Tabrizian P, Parvin-Nejad FP, Fei K, Gunasekaran G, Rocha C, Facciuto ME, Florman S, Schwartz ME. Resection of Mixed Hepatocellular-Cholangiocarcinoma, Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma. Liver Transpl. 2020 Jul;26(7):888-898. doi: 10.1002/lt.25786. PMID: 32352208. |
| Gorbenko K, Mendelev E, Keefer L. Can multidisciplinary team meetings reduce burnout? J Eval Clin Pract. 2020 Jun;26(3):863-865. doi: 10.1111/jep.13234. Epub 2019 Jul 15. PMID: 31304662. |
| Hu L, Gu C, Lopez M, Ji J, Wisnivesky J. Estimation of causal effects of multiple treatments in observational studies with a binary outcome. Stat Methods Med Res. 2020 May 25:962280220921909. doi: 10.1177/0962280220921909. Epub ahead of print. PMID: 32450775. |
| Hu L, Li L, Ji J, Sanderson M. Identifying and understanding determinants of high healthcare costs for breast cancer: a quantile regression machine learning approach. BMC Health Serv Res. 2020 Nov 23;20(1):1066. doi: 10.1186/s12913-020-05936-6. PMID: 33228683; PMCID: PMC7684910. |
| Hu L, Li L, Ji J. Machine learning to identify and understand key factors for provider-patient discussions about smoking. Prev Med Rep. 2020 Nov 5;20:101238. doi: 10.1016/j.pmedr.2020.101238. PMID: 33224719; PMCID: PMC7666379. |
| Li L, Ji J, Besculides M, Bickell N, Margolies LR, Jandorf L, Taioli E, Mazumdar M, Liu B. Factors associated with mammography use: A side-by-side comparison of results from two national surveys. Cancer Med. 2020 Sep;9(17):6430-6451. doi: 10.1002/cam4.3128. Epub 2020 Jul 17. PMID: 32677744; PMCID: PMC7476827. |
| Smith WH, Parikh AB, Li L, Sanderson M, Liu M, Mazumdar M, Isola LM, Dharmarajan KV. Estimating cost implications of potentially avoidable hospitalizations among Oncology Care Model patients with prostate cancer. J Cancer Policy. 2020 Mar;23:100218. doi: 10.1016/j.jcpo.2020.100218. Epub 2020 Jan 14. PMID: 32351875; PMCID: PMC7189771. |
| Liu B, Sze J, Li L, Ornstein KA, Taioli E. Bivariate Spatial Pattern between Smoking Prevalence and Lung Cancer Screening in US Counties. Int J Environ Res Public Health. 2020 May 13;17(10):3383. doi: 10.3390/ijerph17103383. PMID: 32413964; PMCID: PMC7277441. |
| Mazumdar M, Lin JJ, Zhang W, Li L, Liu M, Dharmarajan K, Sanderson M, Isola L, Hu L. Comparison of statistical and machine learning models for healthcare cost data: a simulation study motivated by Oncology Care Model (OCM) data. BMC Health Serv Res. 2020 Apr 25;20(1):350. doi: 10.1186/s12913-020-05148-y. PMID: 32334595; PMCID: PMC7183716. |
| Alberty-Oller JJ, Weltz S, Santos A, Pisapati K, Ru M, Weltz C, Schmidt H, Port E. Adherence to NCCN Guidelines for Genetic Testing in Breast Cancer Patients: Who Are We Missing? Ann Surg Oncol. 2020 Sep 11. doi: 10.1245/s10434-020-09123-z. Epub ahead of print. PMID: 32918176. |
| Blanter J, Zimmerman B, Tharakan S, Ru M, Cascetta K, Tiersten A. BRCA Mutation Association with Recurrence Score and Discordance in a Large Oncotype Database. Oncology. 2020;98(4):248-251. doi: 10.1159/000504965. Epub 2020 Jan 21. PMID: 31962330. |
| Tharakan S, Zimmerman B, Ru M, Blanter J, Cascetta K, Tiersten A. Diabetes and Metformin Association with Recurrence Score in a Large Oncotype Database of Breast Cancer Patients. Oncology. 2020;98(8):589-592. doi: 10.1159/000506076. Epub 2020 Mar 17. PMID: 32182614; PMCID: PMC7415470. |
| Ghiassi-Nejad Z, Sindhu KK, Moshier E, Zubizarreta N, Mazumdar M, Goldstein NE, Dharmarajan KV. Factors associated with the receipt and completion of whole brain radiation therapy among older adults in the United States from 2010-2013. J Geriatr Oncol. 2020 Sep;11(7):1096-1102. doi: 10.1016/j.jgo.2020.03.010. Epub 2020 Mar 31. PMID: 32245729. |
| Naymagon L, Tremblay D, Zubizarreta N, Moshier E, Mascarenhas J, Schiano T. Safety, Efficacy, and Long-Term Outcomes of Anticoagulation in Cirrhotic Portal Vein Thrombosis. Dig Dis Sci. 2020 Nov 5. doi: 10.1007/s10620-020-06695-4. Epub ahead of print. PMID: 33151401. |
| Naymagon L, Tremblay D, Zubizarreta N, Moshier E, Naymagon S, Mascarenhas J, Schiano T. The Natural History, Treatments, and Outcomes of Portal VeinThrombosis in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2020 Mar 18:izaa053. doi: 10.1093/ibd/izaa053. Epub ahead of print. PMID: 32185400. |
| Naymagon L, Tremblay D, Zubizarreta N, Moshier E, Schiano T, Mascarenhas J. Portal vein thrombosis patients harboring JAK2V617F have poor long-term outcomes despite anticoagulation. J Thromb Thrombolysis. 2020 Oct;50(3):652-660. doi: 10.1007/s11239-020-02052-4. PMID: 32034618. |
| Naymagon L, Tremblay D, Zubizarreta N, Moshier E, Troy K, Schiano T, Mascarenhas J. The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosis. Blood Adv. 2020 Feb 25;4(4):655-666. doi: 10.1182/bloodadvances.2019001310. PMID: 32078681; PMCID: PMC7042983. |
| Naymagon L, Zubizarreta N, Feld J, van Gerwen M, Alsen M, Thibaud S, Kessler A, Venugopal S, Makki I, Qin Q, Dharmapuri S, Jun T, Bhalla S, Berwick S, Christian K, Mascarenhas J, Dembitzer F, Moshier E, Tremblay D. Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19. Thromb Res. 2020 Aug 20;196:99-105. doi: 10.1016/j.thromres.2020.08.032. Epub ahead of print. PMID: 32853982; PMCID: PMC7439969. |
| Tremblay D, Madero-Marroquin R, Lancman G, Coltoff A, Feld J, Caro J, Sherlock E, Keyzner A, Navada S, Silverman LR, Moshier E, Zubizarreta N, Mascarenhas J. An Opportunity for Hospice Referral in Acute Myeloid Leukemia: Prognostic Significance of Hospitalization Status at Time of Second Cycle of Hypomethylating Agents for Patients Ineligible for Intensive Induction Chemotherapy. J Palliat Med. 2020 Nov;23(11):1424-1425. doi: 10.1089/jpm.2020.0355. PMID: 33174777. |
| Ashton JC, Bousquet D, Fevrier E, Yip R, Chaudhry S, Port E, Margolies LR. Massage therapy in the breast imaging department: repurposing an ancient anxiety reducing method. Clin Imaging. 2020 May 30;67:49-54. doi: 10.1016/j.clinimag.2020.05.029. Epub ahead of print. PMID: 32516693. |
| Chen X, Ma T, Yip R, Perumalswami PV, Branch AD, Lewis S, Crane M, Yankelevitz DF, Henschke CI. Elevated prevalence of moderate-to-severe hepatic steatosis in World Trade Center General Responder Cohort in a program of CT lung screening. Clin Imaging. 2020 Apr;60(2):237-243. doi: 10.1016/j.clinimag.2019.12.009. Epub 2019 Dec 12. PMID: 31945662; PMCID: PMC7191946. |
| Février E, Yip R, Becker BJ, Taioli E, Yankelevitz DF, Flores R, Henschke CI, Schwartz RM; IELCART Investigators. Change in quality of life of stage IA lung cancer patients after sublobar resection and lobectomy. J Thorac Dis. 2020 Jul;12(7):3488-3499. doi: 10.21037/jtd-20-402. PMID: 32802427; PMCID: PMC7399443. |
| Henschke CI, Yip R, Shaham D, Zulueta JJ, Aguayo SM, Reeves AP, Jirapatnakul A, Avila R, Moghanaki D, Yankelevitz DF; I-ELCAP Investigators. The Regimen of Computed Tomography Screening for Lung Cancer: Lessons Learned Over 25 Years From the International Early Lung Cancer Action Program. J Thorac Imaging. 2020 Jun 5. doi: 10.1097/RTI.0000000000000538. Epub ahead of print. PMID: 32520848. |
| Jirapatnakul A, Reeves AP, Lewis S, Chen X, Ma T, Yip R, Chin X, Liu S, Perumalswami PV, Yankelevitz DF, Crane M, Branch AD, Henschke CI. Automated measurement of liver attenuation to identify moderate-to-severe hepatic steatosis from chest CT scans. Eur J Radiol. 2020 Jan;122:108723. doi: 10.1016/j.ejrad.2019.108723. Epub 2019 Oct 25. PMID: 31778964; PMCID: PMC7179816. |
| Lung cancer screening intervals based on cancer risk. Zhang L, Yip R, Jirapatnakul A, Li M, Cai Q, Henschke CI, Yankelevitz DF; I-ELCAP Investigators. Lung Cancer. 2020 Nov;149:113-119. doi: 10.1016/j.lungcan.2020.09.013. Epub 2020 Sep 23.PMID: 33007677 |
| Management of Nodules Attached to the Costal Pleura at Low-Dose CT Screening for Lung Cancer. Zhu Y, Yip R, You N, Henschke CI, Yankelevitz DF.Radiology. 2020 Dec;297(3):710-718. doi: 10.1148/radiol.2020202388. Epub 2020 Oct 6. PMID: 33021893 |
| Margolies LR, Salvatore M, Tam K, Yip R, Bertolini A, Henschke CI, Yankelevitz DF. Breast mass assessment on chest CT: Axial, sagittal, coronal or maximal intensity projection? Clin Imaging. 2020 Jul;63:60-64. doi: 10.1016/j.clinimag.2020.02.011. Epub 2020 Feb 26. PMID: 32146335. |
| Steiger D, Han D, Yip R, Li K, Chen X, Liu L, Liu J, Ma T, Siddiqi F, Yankelevitz DF, Henschke CI. Increased main pulmonary artery diameter and main pulmonary artery to ascending aortic diameter ratio in smokers undergoing lung cancer screening. Clin Imaging. 2020 Jul;63:16-23. doi: |
| Veronesi G, Baldwin DR, Henschke CI, Ghislandi S, Iavicoli S, Oudkerk M, De Koning HJ, Shemesh J, Field JK, Zulueta JJ, Horgan D, Fiestas Navarrete L, Valentino Infante M, Novellis P, Murray RL, Peled N, Rampinelli C, Rocco G, Rzyman W, Scagliotti GV, Tammemagi MC, Bertolaccini L, Triphuridet N, Yip R, ossi A, Senan S, Ferrante G, Brain K, van der Aalst C, Bonomo L, Consonni D, Van Meerbeeck JP, Maisonneuve P, Novello S, Devaraj A, Saghir Z, Pelosi G. Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe. Cancers (Basel). 2020 Jun 24;12(6):1672. doi: 10.3390/cancers12061672. PMID: 32599792; PMCID: PMC7352874. |
| Wang Y, Zhu Y, Yip R, Lee DS, Flores RM, Kaufman A, Henschke CI, Yankelevitz DF; I-ELCAP Investigators. Pre-surgical assessment of mediastinal lymph node metastases in Stage IA non-small-cell lung cancers. Clin Imaging. 2020 Jun 15;68:61-67. doi: 10.1016/j.clinimag.2020.06.016. Epub ahead of print. PMID: 32570011. |
| Zhu Y, Wang Y, Gioia WE, Yip R, Jirapatnakul AC, Chung MS, Yankelevitz DF, Henschke CI. Visual scoring of aortic valve calcifications on low-dose CT in lung cancer screening. Eur Radiol. 2020 May;30(5):2658-2668. doi: 10.1007/s00330-019-06614-w. Epub 2020 Feb 10. PMID: 32040729. |
| Zhu Y, Yip R, Shemesh J, Jirapatnakul AC, Yankelevitz DF, Henschke CI. Combined aortic valve and coronary artery calcifications in lung cancer screening as predictors of death from cardiovascular disease. Eur Radiol. 2020 Jul 28. doi: 10.1007/s00330-020-07049-4. Epub ahead of print. PMID: 32725329. |
| Dharmapuri S, Özbek U, Lin JY, Sung M, Schwartz M, Branch AD, Ang C. Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in advanced hepatocellular carcinoma patients treated with anti-PD-1 therapy. Cancer Med. 2020 Jul;9(14):4962-4970. doi: 10.1002/cam4.3135. Epub 2020 May 18. PMID: 32419290; PMCID: PMC7367631. |
| Aziz MD, Shah J, Kapoor U, Dimopoulos C, Anand S, Augustine A, Ayuk F, Chaudhry M, Chen YB, Choe HK, Etra A, Gergoudis S, Hartwell MJ, Hexner EO, Hogan WJ, Kitko CL, Kowalyk S, Kröger N, Merli P, Morales G, Nakamura R, Ordemann R, Pulsipher MA, Qayed M, Reshef R, Rösler W, Schechter T, Schreiner E, Srinagesh H, Wölfl M, Wudhikarn K, Yanik G, Young R, Özbek U, Ferrara JLM, Levine JE. Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant. Leukemia. 2020 Jul;34(7):1898-1906. doi: 10.1038/s41375-020-0726-z. Epub 2020 Feb 4. PMID: 32020045; PMCID: PMC7332389. |
| Gergoudis SC, DeFilipp Z, Özbek U, Sandhu KS, Etra AM, Choe HK, Kitko CL, Ayuk F, Aziz M, Baez J, Ben-David K, Bunworasate U, Gandhi I, Hexner EO, Hogan WJ, Holler E, Kasikis S, Kowalyk SM, Lin JY, Merli P, Morales G, Nakamura R, Reshef R, Rösler W, Srinagesh H, Young R, Chen YB, Ferrara JLM, Levine JE. Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin. Blood Adv. 2020 Dec 22;4(24):6098-6105. doi: 10.1182/bloodadvances.2020003336. PMID: 33351103; PMCID: PMC7756981. |
| Cancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes Study. Schmidt AL, Bakouny Z, Bhalla S, Steinharter JA, Tremblay DA, Awad MM, Kessler AJ, Haddad RI, Evans M, Busser F, Wotman M, Curran CR, Zimmerman BS, Bouchard G, Jun T, Nuzzo PV, Qin Q, Hirsch L, Feld J, Kelleher KM, Seidman D, Huang HH, Anderson-Keightly HM, Abou Alaiwi S, Rosenbloom TD, Stewart PS, Galsky MD, Choueiri TK, Doroshow DB. Cancer Cell. 2020 Nov 3:S1535-6108(20)30554-7. doi: 10.1016/j.ccell.2020.10.023. Online ahead of print. PMID: 33176161 Free PMC article. |
| Del Valle DM, Kim-Schulze S, Huang HH, Beckmann ND, Nirenberg S, Wang B, Lavin Y, Swartz TH, Madduri D, Stock A, Marron TU, Xie H, Patel M, Tuballes K, Van Oekelen O, Rahman A, Kovatch P, Aberg JA, Schadt E, Jagannath S, Mazumdar M, Charney AW, Firpo-Betancourt A, Mendu DR, Jhang J, Reich D, Sigel K, Cordon- Cardo C, Feldmann M, Parekh S, Merad M, Gnjatic S. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020 Oct;26(10):1636-1643. doi: 10.1038/s41591-020-1051-9. Epub 2020 Aug 24. PMID: 32839624; PMCID: PMC7869028. |
| Fasano J, Shao T, Huang HH, Kessler AJ, Kolodka OP, Shapiro CL. Optimism and coping: do they influence health outcomes in women with breast cancer? A systemic review and meta-analysis. Breast Cancer Res Treat. 2020 Jul 21. doi: 10.1007/s10549-020-05800-5. Epub ahead of print. PMID: 32691379. |
| Calinawan AP, Song X, Ji J, Dhanasekaran SM, Petralia F, Wang P, Reva B. ProTrack: An Interactive Multi-Omics Data Browser for Proteogenomic Studies. Proteomics. 2020 Nov;20(21-22):e1900359. doi: 10.1002/pmic.201900359. Epub 2020 Aug 6. PMID: 32510176; PMCID: PMC7677200. |
| Petralia F, Tignor N, Reva B, Koptyra M, Chowdhury S, Rykunov D, Krek A, Ma W, Zhu Y, Ji J, Calinawan A, Whiteaker JR, Colaprico A, Stathias V, Omelchenko T, Song X, Raman P, Guo Y, Brown MA, Ivey RG, Szpyt J, Guha Thakurta S, Gritsenko MA, Weitz KK, Lopez G, Kalayci S, Gümüş ZH, Yoo S, da Veiga Leprevost F, Chang HY, Krug K, Katsnelson L, Wang Y, Kennedy JJ, Voytovich UJ, Zhao L, Gaonkar KS, Ennis BM, Zhang B, Baubet V, Tauhid L, Lilly JV, Mason JL, Farrow B, Young N, Leary S, Moon J, Petyuk VA, Nazarian J, Adappa ND, Palmer JN, Lober RM, Rivero-Hinojosa S, Wang LB, Wang JM, Broberg M, Chu RK, Moore RJ, Monroe ME, Zhao R, Smith RD, Zhu J, Robles AI, Mesri M, Boja E, Hiltke T, Rodriguez H, Zhang B, Schadt EE, Mani DR, Ding L, Iavarone A, Wiznerowicz M, Schürer S, Chen XS, Heath AP, Rokita JL, Nesvizhskii AI, Fenyö D, Rodland KD, Liu T, Gygi SP, Paulovich AG, Resnick AC, Storm PB, Rood BR, Wang P; Children’s Brain Tumor Network; Clinical Proteomic Tumor Analysis Consortium. Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer. Cell. 2020 Dec 23;183(7):1962-1985.e31. doi: 10.1016/j.cell.2020.10.044. Epub 2020 Nov 25. PMID: 33242424. |
| Gillette MA, Satpathy S, Cao S, Dhanasekaran SM, Vasaikar SV, Krug K, Petralia F, Li Y, Liang WW, Reva B, Krek A, Ji J, Song X, Liu W, Hong R, Yao L, Blumenberg L, Savage SR, Wendl MC, Wen B, Li K, Tang LC, MacMullan MA, Avanessian SC, Kane MH, Newton CJ, Cornwell M, Kothadia RB, Ma W, Yoo S, Mannan R, Vats P, Kumar-Sinha C, Kawaler EA, Omelchenko T, Colaprico A, Geffen Y, Maruvka YE, da Veiga Leprevost F, Wiznerowicz M, Gümüş ZH, Veluswamy RR, Hostetter G, Heiman DI, Wyczalkowski MA, Hiltke T, Mesri M, Kinsinger CR, Boja ES, Omenn GS, Chinnaiyan AM, Rodriguez H, Li QK, Jewell SD, Thiagarajan M, Getz G, Zhang B, Fenyö D, Ruggles KV, Cieslik MP, Robles AI, Clauser KR, Govindan R, Wang P, Nesvizhskii AI, Ding L, Mani DR, Carr SA; Clinical Proteomic Tumor Analysis Consortium. Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma. Cell. 2020 Jul 9;182(1):200-225.e35. doi: 10.1016/j.cell.2020.06.013. PMID: 32649874; PMCID: PMC7373300. |
| McBride RB, Fei K, Rothstein JH, Alexeeff SE, Song X, Sakoda LC, McGuire V, Achacoso N, Acton L, Liang RY, Lipson JA, Yaffe MJ, Rubin DL, Whittemore AS, Habel LA, Sieh W. Alcohol and Tobacco Use in Relation to Mammographic Density in 23,456 Women. Cancer Epidemiol Biomarkers Prev. 2020 May;29(5):1039-1048. doi: 10.1158/1055-9965.EPI-19-0348. Epub 2020 Feb 17. PMID: 32066618; PMCID: PMC7196522. |
| Yang M, Petralia F, Li Z, Li H, Ma W, Song X, Kim S, Lee H, Yu H, Lee B, Bae S, Heo E, Kaczmarczyk J, Stępniak P, Warchoł M, Yu T, Calinawan AP, Boutros PC, Payne SH, Reva B; NCI-CPTAC-DREAM Consortium, Boja E, Rodriguez H, Stolovitzky G, Guan Y, Kang J, Wang P, Fenyö D, Saez-Rodriguez J. Community Assessment of the Predictability of Cancer Protein and Phosphoprotein Levels from Genomics and Transcriptomics. Cell Syst. 2020 Aug 26;11(2):186-195.e9. doi: 10.1016/j.cels.2020.06.013. Epub 2020 Jul 24. PMID: 32710834. |
2019
| Publication Reference |
| Ferket BS, Veenstra DL. Economic value of exome sequencing for suspected monogenic disorders. Genet Med. 2020 Jun 30. doi: 10.1038/s41436-020-0888-0. Epub ahead of print. PMID: 32601385. |
| Vietti Violi N, Lewis S, Liao J, Hulkower M, Hernandez-Meza G, Smith K, Babb JS, Chin X, Song J, Said D, Kihira S, Sirlin CB, Reeder SB, Bashir MR, Fowler KJ, Ferket BS, Sigel K, Taouli B. Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening. Eur Radiol. 2020 Jun 25. doi: 10.1007/s00330-020-07014-1. Epub ahead of print. PMID: 32588209. |
| Zeidman M, Alberty-Oller JJ, Ru M, Pisapati KV, Moshier E, Ahn S, Mazumdar M, Port E, Schmidt H. Use of neoadjuvant versus adjuvant chemotherapy for hormone receptor-positive breast cancer: a National Cancer Database (NCDB) study. Breast Cancer Res Treat. 2020 Nov;184(1):203-212. doi: 10.1007/s10549-020-05809-w. Epub 2020 Aug 1. PMID: 32740807. |
| Coltoff A, Mesa R, Gotlib J, Shulman J, Rampal RK, Siwoski O, Yacoub A, Moliterno A, Yang A, Braunstein E, Gerds AT, Hobbs GS, Winton EF, Goel S, Wadleigh M, Tremblay D, Moshier E, Mascarenhas J. Real-World Outcomes of Ruxolitinib Treatment for Polycythemia Vera. Clin Lymphoma Myeloma Leuk. 2020 Oct;20(10):697-703.e1. doi: 10.1016/j.clml.2020.05.019. Epub 2020 May 29. PMID: 32624445. |
| Fuller R, Moshier E, Jacobs SE, Tremblay D, Lancman G, Coltoff A, Caro J, Mascarenhas J, Rana M. Practicing Antimicrobial Stewardship: De-Escalating Antibiotics in Patients With Acute Myeloid Leukemia and Neutropenic Fever. Open Forum Infect Dis. 2020 Apr 21;7(5):ofaa138. doi: 10.1093/ofid/ofaa138. PMID: 32420406; PMCID: PMC7216765. |
| Leng S, Moshier E, Tremblay D, Hu L, Biran N, Barman N, Parekh S, Cho H, Madduri D, Richter J, Barlogie B, Jagannath S, Chari A. Timing of Autologous Stem Cell Transplantation for Multiple Myeloma in the Era of Current Therapies. Clin Lymphoma Myeloma Leuk. 2020 Oct;20(10):e734-e751. doi: 10.1016/j.clml.2020.05.027. Epub 2020 Jun 7. PMID: 32660906. |
| Ronner L, Podoltsev N, Gotlib J, Heaney ML, Kuykendall AT, O’Connell C, Shammo J, Fleischman AG, Scherber RM, Mesa R, Yacoub A, Perkins C, Meckstroth S, Behlman L, Chiaramonte M, Salehi M, Ziadkhanpour K, Nguyen H, Siwoski O, Hung AK, Janania Martinez M, Nguyen J, Patel S, Kollipara R, Dave A, Randall M, Grant M, Harrison M, Fernandez Soto P, Tremblay D, Hoffman R, Moshier E, Mascarenhas J. Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis. Blood. 2020 May 7;135(19):1696-1703. doi: 10.1182/blood.2019003347. PMID: 32107559; PMCID: PMC7205813. |
| Sindhu KK, Leiter A, Moshier E, Lin JY, Carroll E, Brooks D, Shimol JB, Eisenberg E, Gallagher EJ, Stock RG, Galsky MD, Buckstein M. Durable disease control with local treatment for oligoprogression of metastatic solid tumors treated with immune checkpoint blockade. Cancer Treat Res Commun. 2020;25:100216. doi: 10.1016/j.ctarc.2020.100216. Epub 2020 Oct 8. PMID: 33049542. |
| Tremblay D, Vogel AS, Moshier E, Hoffman R, Kremyanskaya M, Zhou S, Schiano T, Mascarenhas J. Outcomes of splanchnic vein thrombosis in patients with myeloproliferative neoplasms in a single center experience. Eur J Haematol. 2020 Jan;104(1):72-73. doi: 10.1111/ejh.13335. Epub 2019 Oct 16. PMID: 31587352; PMCID: PMC7781435. |
| Winoker JS, Wajswol E, Falagario U, Maritini A, Moshier E, Voutsinas N, Knauer CJ, Sfakianos JP, Lewis SC, Taouli BA, Rastinehad AR. Transperineal Versus Transrectal Targeted Biopsy With Use of Electromagnetically-tracked MR/US Fusion Guidance Platform for the Detection of Clinically Significant Prostate Cancer. Urology. 2020 Dec;146:278-286. doi: 10.1016/j.urology.2020.07.072. Epub 2020 Sep 18. PMID: 32956688. |
| Zimmerman BS, Seidman D, Berger N, Cascetta KP, Nezolosky M, Trlica K, Ryncarz A, Keeton C, Moshier E, Tiersten A. Patient Perception of Telehealth Services for Breast and Gynecologic Oncology Care during the COVID-19 Pandemic: A Single Center Survey-based Study. J Breast Cancer. 2020 Oct 19;23(5):542-552. doi: 10.4048/jbc.2020.23.e56. PMID: 33154829; PMCID: PMC7604367. |
| DuHamel KN, Schofield EA, Villagra C, Sriphanlop P, Itzkowitz SH, Cotter G, Cohen N, Erwin DO, Winkel G, Thompson HS, Zauber AG, Jandorf LH. Promoting colonoscopy screening among low-income Latinos at average risk of colorectal cancer: A randomized clinical trial. Cancer. 2020 Feb 15;126(4):782-791. doi: 10.1002/cncr.32541. Epub 2019 Nov 19. PMID: 31742670; PMCID: PMC6992525. |
| Cheng FY, Joshi H, Tandon P, Freeman R, Reich DL, Mazumdar M, Kohli-Seth R, Levin M, Timsina P, Kia A. Using Machine Learning to Predict ICU Transfer in Hospitalized COVID-19 Patients. J Clin Med. 2020 Jun 1;9(6):1668. doi: 10.3390/jcm9061668. PMID: 32492874; PMCID: PMC7356638. |
| Kia A, Timsina P, Joshi HN, Klang E, Gupta RR, Freeman RM, Reich DL, Tomlinson MS, Dudley JT, Kohli-Seth R, Mazumdar M, Levin MA. MEWS++: Enhancing the Prediction of Clinical Deterioration in Admitted Patients through a Machine Learning Model. J Clin Med. 2020 Jan 27;9(2):343. doi: 10.3390/jcm9020343. PMID: 32012659; PMCID: PMC7073544. |
| Parchure P, Joshi H, Dharmarajan K, Freeman R, Reich DL, Mazumdar M, Timsina P, Kia A. Development and validation of a machine learning-based prediction model for near-term in-hospital mortality among patients with COVID-19. BMJ Support Palliat Care. 2020 Sep 22:bmjspcare-2020-002602. doi: 10.1136/bmjspcare-2020-002602. Epub ahead of print. PMID: 32963059. |
| Hughley R, Karlic R, Joshi H, Turnbull C, Foulkes WD, Polak P. Etiologic Index – A Case-Only Measure of <i>BRCA1/2</i>-Associated Cancer Risk. N Engl J Med. 2020 Jul 16;383(3):286-288. doi: 10.1056/NEJMc1913988. PMID: 32668122. |
| Haskins SC, Fiasconaro M, Wilson L, Poeran J, Liu J, Memtsoudis S. Ultrasound guidance for peripheral nerve blocks: an observational trend study of national data. Reg Anesth Pain Med. 2020 Feb 12:rapm-2019-101113. doi: 10.1136/rapm-2019-101113. Epub ahead of print. PMID: 32054667. |
| Pavlick A, Blazquez AB, Meseck M, Lattanzi M, Ott PA, Marron TU, Holman RM, Mandeli J, Salazar AM, McClain CB, Gimenez G, Balan S, Gnjatic S, Sabado RL, Bhardwaj N. Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma. Cancer Immunol Res. 2020 Jan;8(1):70-80. doi: 10.1158/2326-6066.CIR-19-0545. Epub 2019 Nov 7. PMID: 31699709; PMCID: PMC6946846. |
| Gallagher EJ, Fei K, Feldman SM, Port E, Friedman NB, Boolbol SK, Killelea B, Pilewskie M, Choi L, King T, Nayak A, Franco R, Cruz D, Antoniou IM, LeRoith D, Bickell NA. Insulin resistance contributes to racial disparities in breast cancer prognosis in US women. Breast Cancer Res. 2020 May 12;22(1):40. doi: 10.1186/s13058-020-01281-y. PMID: 32393319; PMCID: PMC7216707. |
| Holzner ML, Tabrizian P, Parvin-Nejad FP, Fei K, Gunasekaran G, Rocha C, Facciuto ME, Florman S, Schwartz ME. Resection of Mixed Hepatocellular-Cholangiocarcinoma, Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma. Liver Transpl. 2020 Jul;26(7):888-898. doi: 10.1002/lt.25786. PMID: 32352208. |
| Gorbenko K, Mendelev E, Keefer L. Can multidisciplinary team meetings reduce burnout? J Eval Clin Pract. 2020 Jun;26(3):863-865. doi: 10.1111/jep.13234. Epub 2019 Jul 15. PMID: 31304662. |
| Hu L, Gu C, Lopez M, Ji J, Wisnivesky J. Estimation of causal effects of multiple treatments in observational studies with a binary outcome. Stat Methods Med Res. 2020 May 25:962280220921909. doi: 10.1177/0962280220921909. Epub ahead of print. PMID: 32450775. |
| Hu L, Li L, Ji J, Sanderson M. Identifying and understanding determinants of high healthcare costs for breast cancer: a quantile regression machine learning approach. BMC Health Serv Res. 2020 Nov 23;20(1):1066. doi: 10.1186/s12913-020-05936-6. PMID: 33228683; PMCID: PMC7684910. |
| Hu L, Li L, Ji J. Machine learning to identify and understand key factors for provider-patient discussions about smoking. Prev Med Rep. 2020 Nov 5;20:101238. doi: 10.1016/j.pmedr.2020.101238. PMID: 33224719; PMCID: PMC7666379. |
| Li L, Ji J, Besculides M, Bickell N, Margolies LR, Jandorf L, Taioli E, Mazumdar M, Liu B. Factors associated with mammography use: A side-by-side comparison of results from two national surveys. Cancer Med. 2020 Sep;9(17):6430-6451. doi: 10.1002/cam4.3128. Epub 2020 Jul 17. PMID: 32677744; PMCID: PMC7476827. |
| Smith WH, Parikh AB, Li L, Sanderson M, Liu M, Mazumdar M, Isola LM, Dharmarajan KV. Estimating cost implications of potentially avoidable hospitalizations among Oncology Care Model patients with prostate cancer. J Cancer Policy. 2020 Mar;23:100218. doi: 10.1016/j.jcpo.2020.100218. Epub 2020 Jan 14. PMID: 32351875; PMCID: PMC7189771. |
| Liu B, Sze J, Li L, Ornstein KA, Taioli E. Bivariate Spatial Pattern between Smoking Prevalence and Lung Cancer Screening in US Counties. Int J Environ Res Public Health. 2020 May 13;17(10):3383. doi: 10.3390/ijerph17103383. PMID: 32413964; PMCID: PMC7277441. |
| Mazumdar M, Lin JJ, Zhang W, Li L, Liu M, Dharmarajan K, Sanderson M, Isola L, Hu L. Comparison of statistical and machine learning models for healthcare cost data: a simulation study motivated by Oncology Care Model (OCM) data. BMC Health Serv Res. 2020 Apr 25;20(1):350. doi: 10.1186/s12913-020-05148-y. PMID: 32334595; PMCID: PMC7183716. |
| Alberty-Oller JJ, Weltz S, Santos A, Pisapati K, Ru M, Weltz C, Schmidt H, Port E. Adherence to NCCN Guidelines for Genetic Testing in Breast Cancer Patients: Who Are We Missing? Ann Surg Oncol. 2020 Sep 11. doi: 10.1245/s10434-020-09123-z. Epub ahead of print. PMID: 32918176. |
| Blanter J, Zimmerman B, Tharakan S, Ru M, Cascetta K, Tiersten A. BRCA Mutation Association with Recurrence Score and Discordance in a Large Oncotype Database. Oncology. 2020;98(4):248-251. doi: 10.1159/000504965. Epub 2020 Jan 21. PMID: 31962330. |
| Tharakan S, Zimmerman B, Ru M, Blanter J, Cascetta K, Tiersten A. Diabetes and Metformin Association with Recurrence Score in a Large Oncotype Database of Breast Cancer Patients. Oncology. 2020;98(8):589-592. doi: 10.1159/000506076. Epub 2020 Mar 17. PMID: 32182614; PMCID: PMC7415470. |
| Ghiassi-Nejad Z, Sindhu KK, Moshier E, Zubizarreta N, Mazumdar M, Goldstein NE, Dharmarajan KV. Factors associated with the receipt and completion of whole brain radiation therapy among older adults in the United States from 2010-2013. J Geriatr Oncol. 2020 Sep;11(7):1096-1102. doi: 10.1016/j.jgo.2020.03.010. Epub 2020 Mar 31. PMID: 32245729. |
| Naymagon L, Tremblay D, Zubizarreta N, Moshier E, Mascarenhas J, Schiano T. Safety, Efficacy, and Long-Term Outcomes of Anticoagulation in Cirrhotic Portal Vein Thrombosis. Dig Dis Sci. 2020 Nov 5. doi: 10.1007/s10620-020-06695-4. Epub ahead of print. PMID: 33151401. |
| Naymagon L, Tremblay D, Zubizarreta N, Moshier E, Naymagon S, Mascarenhas J, Schiano T. The Natural History, Treatments, and Outcomes of Portal VeinThrombosis in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2020 Mar 18:izaa053. doi: 10.1093/ibd/izaa053. Epub ahead of print. PMID: 32185400. |
| Naymagon L, Tremblay D, Zubizarreta N, Moshier E, Schiano T, Mascarenhas J. Portal vein thrombosis patients harboring JAK2V617F have poor long-term outcomes despite anticoagulation. J Thromb Thrombolysis. 2020 Oct;50(3):652-660. doi: 10.1007/s11239-020-02052-4. PMID: 32034618. |
| Naymagon L, Tremblay D, Zubizarreta N, Moshier E, Troy K, Schiano T, Mascarenhas J. The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosis. Blood Adv. 2020 Feb 25;4(4):655-666. doi: 10.1182/bloodadvances.2019001310. PMID: 32078681; PMCID: PMC7042983. |
| Naymagon L, Zubizarreta N, Feld J, van Gerwen M, Alsen M, Thibaud S, Kessler A, Venugopal S, Makki I, Qin Q, Dharmapuri S, Jun T, Bhalla S, Berwick S, Christian K, Mascarenhas J, Dembitzer F, Moshier E, Tremblay D. Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19. Thromb Res. 2020 Aug 20;196:99-105. doi: 10.1016/j.thromres.2020.08.032. Epub ahead of print. PMID: 32853982; PMCID: PMC7439969. |
| Tremblay D, Madero-Marroquin R, Lancman G, Coltoff A, Feld J, Caro J, Sherlock E, Keyzner A, Navada S, Silverman LR, Moshier E, Zubizarreta N, Mascarenhas J. An Opportunity for Hospice Referral in Acute Myeloid Leukemia: Prognostic Significance of Hospitalization Status at Time of Second Cycle of Hypomethylating Agents for Patients Ineligible for Intensive Induction Chemotherapy. J Palliat Med. 2020 Nov;23(11):1424-1425. doi: 10.1089/jpm.2020.0355. PMID: 33174777. |
| Ashton JC, Bousquet D, Fevrier E, Yip R, Chaudhry S, Port E, Margolies LR. Massage therapy in the breast imaging department: repurposing an ancient anxiety reducing method. Clin Imaging. 2020 May 30;67:49-54. doi: 10.1016/j.clinimag.2020.05.029. Epub ahead of print. PMID: 32516693. |
| Chen X, Ma T, Yip R, Perumalswami PV, Branch AD, Lewis S, Crane M, Yankelevitz DF, Henschke CI. Elevated prevalence of moderate-to-severe hepatic steatosis in World Trade Center General Responder Cohort in a program of CT lung screening. Clin Imaging. 2020 Apr;60(2):237-243. doi: 10.1016/j.clinimag.2019.12.009. Epub 2019 Dec 12. PMID: 31945662; PMCID: PMC7191946. |
| Février E, Yip R, Becker BJ, Taioli E, Yankelevitz DF, Flores R, Henschke CI, Schwartz RM; IELCART Investigators. Change in quality of life of stage IA lung cancer patients after sublobar resection and lobectomy. J Thorac Dis. 2020 Jul;12(7):3488-3499. doi: 10.21037/jtd-20-402. PMID: 32802427; PMCID: PMC7399443. |
| Henschke CI, Yip R, Shaham D, Zulueta JJ, Aguayo SM, Reeves AP, Jirapatnakul A, Avila R, Moghanaki D, Yankelevitz DF; I-ELCAP Investigators. The Regimen of Computed Tomography Screening for Lung Cancer: Lessons Learned Over 25 Years From the International Early Lung Cancer Action Program. J Thorac Imaging. 2020 Jun 5. doi: 10.1097/RTI.0000000000000538. Epub ahead of print. PMID: 32520848. |
| Jirapatnakul A, Reeves AP, Lewis S, Chen X, Ma T, Yip R, Chin X, Liu S, Perumalswami PV, Yankelevitz DF, Crane M, Branch AD, Henschke CI. Automated measurement of liver attenuation to identify moderate-to-severe hepatic steatosis from chest CT scans. Eur J Radiol. 2020 Jan;122:108723. doi: 10.1016/j.ejrad.2019.108723. Epub 2019 Oct 25. PMID: 31778964; PMCID: PMC7179816. |
| Lung cancer screening intervals based on cancer risk. Zhang L, Yip R, Jirapatnakul A, Li M, Cai Q, Henschke CI, Yankelevitz DF; I-ELCAP Investigators. Lung Cancer. 2020 Nov;149:113-119. doi: 10.1016/j.lungcan.2020.09.013. Epub 2020 Sep 23.PMID: 33007677 |
| Management of Nodules Attached to the Costal Pleura at Low-Dose CT Screening for Lung Cancer. Zhu Y, Yip R, You N, Henschke CI, Yankelevitz DF.Radiology. 2020 Dec;297(3):710-718. doi: 10.1148/radiol.2020202388. Epub 2020 Oct 6. PMID: 33021893 |
| Margolies LR, Salvatore M, Tam K, Yip R, Bertolini A, Henschke CI, Yankelevitz DF. Breast mass assessment on chest CT: Axial, sagittal, coronal or maximal intensity projection? Clin Imaging. 2020 Jul;63:60-64. doi: 10.1016/j.clinimag.2020.02.011. Epub 2020 Feb 26. PMID: 32146335. |
| Steiger D, Han D, Yip R, Li K, Chen X, Liu L, Liu J, Ma T, Siddiqi F, Yankelevitz DF, Henschke CI. Increased main pulmonary artery diameter and main pulmonary artery to ascending aortic diameter ratio in smokers undergoing lung cancer screening. Clin Imaging. 2020 Jul;63:16-23. doi: |
| Veronesi G, Baldwin DR, Henschke CI, Ghislandi S, Iavicoli S, Oudkerk M, De Koning HJ, Shemesh J, Field JK, Zulueta JJ, Horgan D, Fiestas Navarrete L, Valentino Infante M, Novellis P, Murray RL, Peled N, Rampinelli C, Rocco G, Rzyman W, Scagliotti GV, Tammemagi MC, Bertolaccini L, Triphuridet N, Yip R, ossi A, Senan S, Ferrante G, Brain K, van der Aalst C, Bonomo L, Consonni D, Van Meerbeeck JP, Maisonneuve P, Novello S, Devaraj A, Saghir Z, Pelosi G. Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe. Cancers (Basel). 2020 Jun 24;12(6):1672. doi: 10.3390/cancers12061672. PMID: 32599792; PMCID: PMC7352874. |
| Wang Y, Zhu Y, Yip R, Lee DS, Flores RM, Kaufman A, Henschke CI, Yankelevitz DF; I-ELCAP Investigators. Pre-surgical assessment of mediastinal lymph node metastases in Stage IA non-small-cell lung cancers. Clin Imaging. 2020 Jun 15;68:61-67. doi: 10.1016/j.clinimag.2020.06.016. Epub ahead of print. PMID: 32570011. |
| Zhu Y, Wang Y, Gioia WE, Yip R, Jirapatnakul AC, Chung MS, Yankelevitz DF, Henschke CI. Visual scoring of aortic valve calcifications on low-dose CT in lung cancer screening. Eur Radiol. 2020 May;30(5):2658-2668. doi: 10.1007/s00330-019-06614-w. Epub 2020 Feb 10. PMID: 32040729. |
| Zhu Y, Yip R, Shemesh J, Jirapatnakul AC, Yankelevitz DF, Henschke CI. Combined aortic valve and coronary artery calcifications in lung cancer screening as predictors of death from cardiovascular disease. Eur Radiol. 2020 Jul 28. doi: 10.1007/s00330-020-07049-4. Epub ahead of print. PMID: 32725329. |
| Dharmapuri S, Özbek U, Lin JY, Sung M, Schwartz M, Branch AD, Ang C. Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in advanced hepatocellular carcinoma patients treated with anti-PD-1 therapy. Cancer Med. 2020 Jul;9(14):4962-4970. doi: 10.1002/cam4.3135. Epub 2020 May 18. PMID: 32419290; PMCID: PMC7367631. |
| Aziz MD, Shah J, Kapoor U, Dimopoulos C, Anand S, Augustine A, Ayuk F, Chaudhry M, Chen YB, Choe HK, Etra A, Gergoudis S, Hartwell MJ, Hexner EO, Hogan WJ, Kitko CL, Kowalyk S, Kröger N, Merli P, Morales G, Nakamura R, Ordemann R, Pulsipher MA, Qayed M, Reshef R, Rösler W, Schechter T, Schreiner E, Srinagesh H, Wölfl M, Wudhikarn K, Yanik G, Young R, Özbek U, Ferrara JLM, Levine JE. Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant. Leukemia. 2020 Jul;34(7):1898-1906. doi: 10.1038/s41375-020-0726-z. Epub 2020 Feb 4. PMID: 32020045; PMCID: PMC7332389. |
| Gergoudis SC, DeFilipp Z, Özbek U, Sandhu KS, Etra AM, Choe HK, Kitko CL, Ayuk F, Aziz M, Baez J, Ben-David K, Bunworasate U, Gandhi I, Hexner EO, Hogan WJ, Holler E, Kasikis S, Kowalyk SM, Lin JY, Merli P, Morales G, Nakamura R, Reshef R, Rösler W, Srinagesh H, Young R, Chen YB, Ferrara JLM, Levine JE. Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin. Blood Adv. 2020 Dec 22;4(24):6098-6105. doi: 10.1182/bloodadvances.2020003336. PMID: 33351103; PMCID: PMC7756981. |
| Cancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes Study. Schmidt AL, Bakouny Z, Bhalla S, Steinharter JA, Tremblay DA, Awad MM, Kessler AJ, Haddad RI, Evans M, Busser F, Wotman M, Curran CR, Zimmerman BS, Bouchard G, Jun T, Nuzzo PV, Qin Q, Hirsch L, Feld J, Kelleher KM, Seidman D, Huang HH, Anderson-Keightly HM, Abou Alaiwi S, Rosenbloom TD, Stewart PS, Galsky MD, Choueiri TK, Doroshow DB. Cancer Cell. 2020 Nov 3:S1535-6108(20)30554-7. doi: 10.1016/j.ccell.2020.10.023. Online ahead of print. PMID: 33176161 Free PMC article. |
| Del Valle DM, Kim-Schulze S, Huang HH, Beckmann ND, Nirenberg S, Wang B, Lavin Y, Swartz TH, Madduri D, Stock A, Marron TU, Xie H, Patel M, Tuballes K, Van Oekelen O, Rahman A, Kovatch P, Aberg JA, Schadt E, Jagannath S, Mazumdar M, Charney AW, Firpo-Betancourt A, Mendu DR, Jhang J, Reich D, Sigel K, Cordon- Cardo C, Feldmann M, Parekh S, Merad M, Gnjatic S. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020 Oct;26(10):1636-1643. doi: 10.1038/s41591-020-1051-9. Epub 2020 Aug 24. PMID: 32839624; PMCID: PMC7869028. |
| Fasano J, Shao T, Huang HH, Kessler AJ, Kolodka OP, Shapiro CL. Optimism and coping: do they influence health outcomes in women with breast cancer? A systemic review and meta-analysis. Breast Cancer Res Treat. 2020 Jul 21. doi: 10.1007/s10549-020-05800-5. Epub ahead of print. PMID: 32691379. |
| Calinawan AP, Song X, Ji J, Dhanasekaran SM, Petralia F, Wang P, Reva B. ProTrack: An Interactive Multi-Omics Data Browser for Proteogenomic Studies. Proteomics. 2020 Nov;20(21-22):e1900359. doi: 10.1002/pmic.201900359. Epub 2020 Aug 6. PMID: 32510176; PMCID: PMC7677200. |
| Petralia F, Tignor N, Reva B, Koptyra M, Chowdhury S, Rykunov D, Krek A, Ma W, Zhu Y, Ji J, Calinawan A, Whiteaker JR, Colaprico A, Stathias V, Omelchenko T, Song X, Raman P, Guo Y, Brown MA, Ivey RG, Szpyt J, Guha Thakurta S, Gritsenko MA, Weitz KK, Lopez G, Kalayci S, Gümüş ZH, Yoo S, da Veiga Leprevost F, Chang HY, Krug K, Katsnelson L, Wang Y, Kennedy JJ, Voytovich UJ, Zhao L, Gaonkar KS, Ennis BM, Zhang B, Baubet V, Tauhid L, Lilly JV, Mason JL, Farrow B, Young N, Leary S, Moon J, Petyuk VA, Nazarian J, Adappa ND, Palmer JN, Lober RM, Rivero-Hinojosa S, Wang LB, Wang JM, Broberg M, Chu RK, Moore RJ, Monroe ME, Zhao R, Smith RD, Zhu J, Robles AI, Mesri M, Boja E, Hiltke T, Rodriguez H, Zhang B, Schadt EE, Mani DR, Ding L, Iavarone A, Wiznerowicz M, Schürer S, Chen XS, Heath AP, Rokita JL, Nesvizhskii AI, Fenyö D, Rodland KD, Liu T, Gygi SP, Paulovich AG, Resnick AC, Storm PB, Rood BR, Wang P; Children’s Brain Tumor Network; Clinical Proteomic Tumor Analysis Consortium. Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer. Cell. 2020 Dec 23;183(7):1962-1985.e31. doi: 10.1016/j.cell.2020.10.044. Epub 2020 Nov 25. PMID: 33242424. |
| Gillette MA, Satpathy S, Cao S, Dhanasekaran SM, Vasaikar SV, Krug K, Petralia F, Li Y, Liang WW, Reva B, Krek A, Ji J, Song X, Liu W, Hong R, Yao L, Blumenberg L, Savage SR, Wendl MC, Wen B, Li K, Tang LC, MacMullan MA, Avanessian SC, Kane MH, Newton CJ, Cornwell M, Kothadia RB, Ma W, Yoo S, Mannan R, Vats P, Kumar-Sinha C, Kawaler EA, Omelchenko T, Colaprico A, Geffen Y, Maruvka YE, da Veiga Leprevost F, Wiznerowicz M, Gümüş ZH, Veluswamy RR, Hostetter G, Heiman DI, Wyczalkowski MA, Hiltke T, Mesri M, Kinsinger CR, Boja ES, Omenn GS, Chinnaiyan AM, Rodriguez H, Li QK, Jewell SD, Thiagarajan M, Getz G, Zhang B, Fenyö D, Ruggles KV, Cieslik MP, Robles AI, Clauser KR, Govindan R, Wang P, Nesvizhskii AI, Ding L, Mani DR, Carr SA; Clinical Proteomic Tumor Analysis Consortium. Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma. Cell. 2020 Jul 9;182(1):200-225.e35. doi: 10.1016/j.cell.2020.06.013. PMID: 32649874; PMCID: PMC7373300. |
| McBride RB, Fei K, Rothstein JH, Alexeeff SE, Song X, Sakoda LC, McGuire V, Achacoso N, Acton L, Liang RY, Lipson JA, Yaffe MJ, Rubin DL, Whittemore AS, Habel LA, Sieh W. Alcohol and Tobacco Use in Relation to Mammographic Density in 23,456 Women. Cancer Epidemiol Biomarkers Prev. 2020 May;29(5):1039-1048. doi: 10.1158/1055-9965.EPI-19-0348. Epub 2020 Feb 17. PMID: 32066618; PMCID: PMC7196522. |
| Yang M, Petralia F, Li Z, Li H, Ma W, Song X, Kim S, Lee H, Yu H, Lee B, Bae S, Heo E, Kaczmarczyk J, Stępniak P, Warchoł M, Yu T, Calinawan AP, Boutros PC, Payne SH, Reva B; NCI-CPTAC-DREAM Consortium, Boja E, Rodriguez H, Stolovitzky G, Guan Y, Kang J, Wang P, Fenyö D, Saez-Rodriguez J. Community Assessment of the Predictability of Cancer Protein and Phosphoprotein Levels from Genomics and Transcriptomics. Cell Syst. 2020 Aug 26;11(2):186-195.e9. doi: 10.1016/j.cels.2020.06.013. Epub 2020 Jul 24. PMID: 32710834. |